| COMPANY | SYMBOL | PRICE | Shares | Trade Date | UNDERWRITER (S) |
| 10x Genomics, Inc. | TXG | $31.00-$35.00 | 9 million | 9/12/2019 | JP Morgan, Goldman Sachs, BofA Merrill Lynch |
| 1Life Healthcare, Inc. | ONEM | $14.00-$16.00 | 17.5 million | 1/31/2020 | JP Morgan, Morgan Stanley, Allen & Co., Citigroup, Piper Jaffray, Wells Fargo, William Blair |
| 4D Molecular Therapeutics, Inc. | FDMT | $22.00-$23.00 | 8.4 million | 12/11/2020 | Goldman Sachs, BofA Securities, Evercore |
| 89bio, Inc. | ETNB | $15.00-$17.00 | 5.3 million | 11/11/2019 | BofA Merrill Lynch, SVB Leerink, RBC Capital
|
| 908 Devices Inc. | MASS | $18.00-$19.00 | 6.5 million | 12/18/2020 | Cowen, SVB Leerink William Blair, Stifel
|
| AAC Holdings, Inc. | AAC | $12.00-$14.00 | 5 million | 10/2/2014 | William Blair, Raymond James |
| Abcam plc | ABCM | $16.52-$16.52 | 8.95 million ADSs | 10/22/2020 | Morgan Stanley, BofA Securities, SVB Leerink
|
| AbCellera Biologics, Inc. | ABCL | $14.00-$17.00 | 24.15 million | 12/11/2020 | Credit Suisse, Stifel, Berenberg, SVB Leerink, BMO Capital Markets |
| Ablynx NV | ABLX | $17.90-$19.08 | 11.43 million ADSs | 10/25/2017 | BofA Merrill Lynch, J.P. Morgan, Jefferies |
| Abpro Corporation | ABP | Withdrawn | Withdrawn | 5/11/2018 | UBS Investment Bank, Wells Fargo Securities, Nomura, Oppenheimer & Co. |
| AbSci Corporation | ABSI | $15.00-$17.00 | 12.5 million | 7/22/2021 | J.P. Morgan, Credit Suisse, BofA Securities, Cowen, Stifel
|
| AC Immune SA | ACIU | $11.00-$13.00 | 6 million | 9/23/2016 | Credit Suisse, Jefferies, Leerink Partners |
| Accelerated Pharma | ACCP | $4.00-$6.00 | Postponed | 7/21/2017 | Rodman & Renshaw, Joseph Gunnar & Co. |
| Acceleron Pharma | XLRN | $13.00-$15.00 | 5.6 million | 9/19/2013 | Citigroup, Leerink Swann, Piper Jaffray |
| Accolade Inc. | ACCD | $19.00-$21.00 | 10 million | 7/2/2020 | Goldman Sachs, Morgan Stanley, BofA Securities, Piper Sandler, Credit Suisse, William Blair |
| Acelity Holdings | TBD | Withdrawn | TBD | 0/0/0 | J.P. Morgan, Goldman Sachs & Co., BofA Merrill Lynch
|
| ACell, Inc. | ACLL | $14.00-$16.00 | 5 million | 0/0/0 | UBS Investment Bank, Barclays, RBC Capital Markets |
| ACELYRIN, Inc. | SLRN | 30 million | $16.00-$18.00 | 5/5/2023 | Morgan Stanley, Jefferies, TD Cowen, Piper Sandler |
| Achaogen, Inc. | AKAO | $12.00-$14.00 | 6 million | 3/12/2014 | Credit Suisse, Cowen & Co. |
| Achilles Therapeutics Inc. | ACHL | $17.00-$19.00 | 9.75 million ADSs | 3/31/2021 | JP Morgan, BofA Securities, Piper Sandler |
| Aclaris Therapeutics | ACRS | $14.00-$16.00 | 5 million | 10/7/2015 | Jefferies, Citigroup |
| Acrivon Therapeutics, Inc. | ACRV | $16.00-$18.00 | 7.5 million | 11/15/2022 | Jefferies, Cowen, Piper Sandler |
| Acumen Pharmaceuticals | ABOS | $14.00-$16.00 | 10 million | 7/1/2021 | BofA Securities, Credit Suisse, Stifel |
| Acutus Medical Inc | AFIB | $16.00-$18.00 | 8.8 million | 8/6/2020 | J.P. Morgan, BofA Securities, William Blair |
| Adagene Inc. | ADAG | $17.00-$19.00 | 7.4 million ADSs | 2/9/2021 | Goldman Sachs, Morgan Stanley, Jefferies |
| Adagio Therapeutics, Inc. | ADGI | $16.00-$18.00 | 18.2 million | 8/6/2021 | Morgan Stanley, Jefferies, Stifel, Guggenheim Securities |
| Adamas Pharmaceuticals | ADMS | $16.00-$18.00 | 3 million | 4/10/2014 | Credit Suisse, Piper Jaffray |
| AdaptImmune Therapeutics | ADAP | $15.00-$17.00 | 11.25 million | 5/6/2015 | BofA Merrill Lynch, Cowen & Co., Leerink Partners
|
| Adaptive Biotechnologies Corporation | ADPT | $15.00-$17.00 | 15 million | 6/27/2019 | Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch |
| ADC Therapeutics SA | ADCT | $16.00-$18.00 | 12.3 million | 5/15/2020 | Morgan Stanley, BofA Merrill Lynch, Cowen |
| Adeptus Health | ADPT | $19.00-$22.00 | 4.9 million | 6/25/2014 | Deutsche Bank Securities, Goldman Sachs & Co., Evercore, Morgan Stanley |
| Adial Pharmaceuticals | ADIL | $5.00-$5.00 | 1.5 million | 7/27/2018 | Joseph Gunnar & Co. |
| ADMA Biologics | ADMA | $8.50-$9.50 | 3.35 million | 10/17/2013 | Oppenheimer & Co., BMO Capital Markets |
| Aduro Biotech | ADRO | $14.00-$16.00 | 7 million | 4/15/2015 | BofA Merrill Lynch, Leerink Partners |
| Advanced Accelerator Applications S.A. | AAAP | $15.00-$17.00 | 4.7 million | 11/11/2015 | Citigroup, Jefferies |
| Advanced Inhalation Therapies, Ltd. | AITPU | $15.00-$15.00 | 333,333 | 0/0/0 | Joseph Gunnar & Co. |
| Aeglea Therapeutics, Inc. | AGLE | $16.00-$18.00 | 5 million | 4/7/2016 | UBS Investment Bank, BMO Capital Markets, Wells Fargo Securities
|
| AEON Biopharma, Inc | AEON | Postponed | Postponed | 10/8/2021 | Wells Fargo, Cantor, Mizuho Securities |
| Aerie Pharmaceuticals | AERI | $12.00-$14.00 | 6.72 million | 10/25/2013 | RBC Capital Markets, Stifel Nicolaus Weisel |
| Aerovate Therapeutics | AVTE | $13.00-$15.00 | 8.7 million | 6/30/2021 | Jefferies, Cowen, Evercore |
| Aesthetic Medical International Holdings Group Limited | AIH | 11.00-$13.00 | 2.5 million ADSs | 10/25/2019 | Cantor, Haitong International, Prime Number Capital |
| Affimed Therapeutics B.V. | AFMD | $11.00-$13.00 | 8 million | 9/12/2014 | Jefferies, Leerink Partners BMO Capital Markets |
| Affinia Therapeutics Inc. | AFTX | Withdrawn | Withdrawn | 0/0/0 | Goldman Sachs, Jefferies, Piper Sandler |
| Agendia N.V. | AGDX | Withdrawn | Withdrawn | 0/0/0 | Goldman Sachs, Citigroup, Cowen, Stifel |
| Agile Therapeutics, Inc. | AGRX | $6.00-$6.00 | 9.2 million | 5/23/2014 | RBC Capital Markets, William Blair |
| Agiliti, Inc | AGTI | $18.00-$20.00 | 26.3 million | 4/23/2021 | BofA Securities, Goldman Sachs, Morgan Stanley, BMO Capital Market, Citigroup, Jefferies, UBS Investment Bank |
| agilon health, Inc. | AGL | $20.00-$23.00 | 46.6 million | 4/15/2021 | JP Morgan, Goldman Sachs, BofA Securities, Deutsche Bank, Wells Fargo |
| Agios Pharmaceuticals | AGIO | $14.00-$16.00 | 5 million | 7/24/2014 | J.P. Morgan, Goldman Sachs |
| Aileron Therapeutics, Inc. | ALRN | $15.00-$17.00 | 3.75 million | 6/29/2017 | BofA Merrill Lynch, Jefferies |
| Aimmune Therapeutics, Inc. | AIMT | $14.00-$16.00 | 10 million | 8/6/2015 | BofA Merrill Lynch, Credit Suisse, Piper Jaffray |
| Akcea Therapeutics, Inc. | AKCA | $12.00-$14.00 | 15.63 million | 7/14/2017 | Cowen and Company, Stifel, Wells Fargo Securities |
| Akebia Therapeutics | AKBA | $14.00-$17.00 | 5.88 million | 3/20/2014 | Morgan Stanley, Credit Suisse |
| Akero Therapeutics | AKRO | $14.00-$16.00 | 5.75 million | 6/20/2019 | JP Morgan, Jefferies, Evercore ISI |
| Akouos, Inc. | AKUS | $14.00-$16.00 | 12.5 million | 6/26/2020 | BofA Securities, Cowen, Piper Sandler |
| Akoya Biosciences, Inc. | AKYA | $18.00-$20.00 | 6.6 million | 4/16/2021 | JP Morgan, Morgan Stanley, Piper Sandler, Canaccord Genuity |
| Alcobra Ltd. | ADHD | $10.00-$12.00 | 3.125 million | 5/22/2013 | Aegis Capital Corp |
| Alder Biopharmaceuticals | ALDR | $13.00-$15.00 | 7.15 million | 5/8/2014 | Credit Suisse, Leerink Partners. |
| Alector, Inc. | ALEC | $18.00-$20.00 | 9.25 million | 2/7/2019 | Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays |
| Alignment Healthcare, Inc. | ALHC | $17.00-$19.00 | 27.2 million | 3/26/2021 | Goldman Sachs, Morgan Stanley, JP Morgan, BofA Securities, William Blair |
| Aligos Therapeutics, Inc | ALGS | $14.00-$16.00 | 10 million | 10/16/2020 | J.P. Morgan, Jefferies, Piper Sandler |
| Allakos Inc. | ALLK | $15.00-$17.00 | 7.2 million | 7/19/2018 | Goldman Sachs, Jefferies |
| Allena Pharmaceuticals, Inc. | ALNA | $14.00-$16.00 | 5.3 million | 11/2/2017 | Credit Suisse, Jefferies, Cowen & Company |
| Allogene Therapeutics, Inc. | ALLO | $16.00-$18.00 | 18 million | 10/11/2018 | Goldman Sachs & Co, J.P. Morgan, Cowen, Jefferies |
| AlloVir, Inc. | ALVR | $16.00-$18.00 | 16.25 million | 7/30/2020 | Morgan Stanley, JP Morgan, SVB Leerink, Piper Sandler |
| Alpha Teknova, Inc. | TKNO | $14.00-$16.00 | 6 million | 6/25/2021 | Cowen, William Blair
|
| Alto Neuroscience, Inc. | ANRO | $14.00-$16.00 | 8.04 million | 2/2/2024 | Jefferies, TD Cowen, Stifel, William Blair |
| Alumis Inc. | ALMS | $16.00-$18.00 | 13.125 million | 6/28/2024 | Morgan Stanley, Leerink Partners, Cantor, Guggenheim Securities |
| ALX Oncology Holdings Inc. | ALXO | $15.00-$17.00 | 8.5 million | 7/17/2020 | Jefferies, Credit Suisse, Piper Sandler, Cantor |
| Alzheon, Inc. | ALZH | Withdrawn | Withdrawn | 0/0/0 | ThinkEquity, H.C. Wainwright |
| Ambit Biosciences Corporation | AMBI | $8.00-$8.00 | 8.1 million | 5/16/2013 | Citigroup, Leerink Swann |
| Ambrx Biopharma Inc | AMAM | $17.00-$19.00 | 7.0 million ADSs | 6/18/2021 | Goldman Sachs, BofA Securities, Cowen |
| Amedica Corporation | AMDA | $8.00-$10.00 | 3.5 million | 2/13/2014 | JMP Securities |
| American Renal Associates Holdings | ARA | $20.00-$23.00 | 7.5 million | 4/21/2016 | BofA Merrill Lynch, Barclays, Goldman Sachs & Co., Wells Fargo Securities, SunTrust Robinson Humphrey
|
| Amphastar Pharmaceuticals | AMPH | $10.00-$12.00 | 8 million | 6/25/2014 | Jefferies, BMO Capital Markets, Piper Jaffray |
| Amylyx Pharmaceuticals, Inc. | AMLX | $18.00-$20.00 | 10 million | 1/7/2022 | Goldman Sachs, SVB Leerink, Evercore ISI |
| AN2 Therapeutics, Inc. | ANTX | $14.00-$16.00 | 4.6 million | 3/25/2022 | Cowen, SVB Leerink, Evercore ISI
|
| AnaptysBio, Inc. | ANAB | $14.00-$16.00 | 5 million | 1/26/2017 | Credit Suisse, Stifel
|
| Anchiano Therapeutics Ltd. | ANCN | $14.55-$14.55 | 2.65 million ADSs | 2/12/2019 | Oppenheimer & Co. |
| Angion Biomedica Corp. | ANGN | $14.00-$16.00 | 5 million | 2/5/2021 | Cowen, Stifel |
| Annexon, Inc. | ANNX | $15.00-$16.00 | 14.75 million | 7/24/2020 | JP Morgan, BofA Securities, Cowen |
| Apellis Pharmaceuticals | APLS | $13.00-$15.00 | 10.7 million | 11/9/2017 | Citigroup, J.P. Morgan, Evercore ISI |
| Apogee Therapeutics, Inc. | APGE | $15.00-$17.00 | 17.7 million | 7/14/2023 | Jefferies, TD Cowen, Stifel, Guggenheim Securities |
| Applied Genetic Technologies Corp | AGTC | $13.00-$15.00 | 4.2 million | 3/27/2014 | BMO Capital Markets, Wedbush PacGrow Life Science |
| Applied Molecular Transport Inc. | AMTI | $12.00-$14.00 | 11 million | 6/5/2020 | BofA Securities, Jefferies, SVB Leerink |
| Applied Therapeutics, Inc. | APLT | $14.00-$16.00 | 4 million | 5/14/2019 | Citigroup, Cowen, UBS Investment Bank |
| Aprea Therapeutics, Inc. | APRE | $14.00-$16.00 | 5.7 million | 10/3/2019 | JP Morgan, Morgan Stanley, RBC Capital |
| Apria, Inc. | APR | $19.00-$21.00 | 7.5 million | 2/11/2021 | Citigroup, Goldman Sachs, BofA Securities, JP Morgan |
| Aptinyx, Inc. | APTX | $14.00-$16.00 | 6.4 million | 6/21/2018 | J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets |
| Aquestive Therapeutics, Inc. | AQST | $14.00-$16.00 | 4.5 million | 7/25/2018 | BMO, RBC |
| Aquinox Pharmaceuticals, Inc. | AQXP | $10.00-$12.00 | 4.2 million | 3/7/2014 | Jefferies, Cowen & Co. |
| Aratana Therapeutics | PETX | $11.00-$13.00 | 5.75 million | 6/27/2013 | Stifel, Lazard Capital |
| Arcadia Biosciences, Inc. | RKDA | $13.00-$15.00 | 8.2 million | 5/15/2015 | Credit Suisse, J.P. Morgan, Piper Jaffray |
| Arcellx, Inc. | ACLX | $15.00-$17.00 | 8.25 million | 2/4/2022 | BofA Securities, SVB Leerink, Barclays, William Blair |
| ArcherDX, Inc. | RCHR | Withdrawn | Withdrawn | 0/0/0 | JP Morgan, BofA Securities, Stifel, Evercore ISI |
| Arcus Biosciences, Inc. | RCUS | $13.00-$15.00 | 8 million | 3/15/2018 | Citigroup, Goldman Sachs & Co., Leerink Partners |
| Arcutis Biotherapeutics Inc. | ARQT | $15.00-$17.00 | 9.6 million | 1/31/2020 | Goldman Sachs, Cowen, Guggenheim Securities |
| Ardelyx Inc., | ARDX | $13.00-$15.00 | 4.3 million | 6/19/2014 | Citigroup, Leerink Partners |
| Ardent Health Partners, Inc. | ARDT | $20.00-$22.00 | 12 million | 7/18/2024 | J.P. Morgan, BofA Securities, Morgan Stanley, Stephens Inc, Citigroup, Leerink Partners, RBC Capital Markets, Truist Securities, Mizuho, Capital One Securities, Loop Capital Markets |
| Argenx N.V. | ARGX | Last Trade $18.18 | 5.0 million ADS | 5/18/2017 | Cowen and Company, Piper Jaffray |
| Argos Therapeutics | ARGS | $13.00-$15.00 | 5.63 million | 2/7/2014 | Piper Jaffray, Stifel, JMP Securities |
| Aridis Pharmaceuticals, Inc. | ARDS | $13.00-$15.00 | 2 million | 8/14/2018 | Cantor, Maxim Group |
| ARMO BioSciences, Inc. | ARMO | $14.00-$16.00 | 7.5 million | 1/26/2018 | Jefferies, Leerink, BMO Capital Markets |
| Arog Pharmaceuticals, Inc. | AROG | Withdrawn | Withdrawn | 0/0/0 | Citigroup, RBC Capital, Nomura |
| ArriVent BioPharma Inc | AVBP | $17.00-$19.00 | 9.7 million | 1/26/2024 | Goldman Sachs, Jefferies, Citigroup |
| Arsanis, Inc. | ASNS | $15.00-$17.00 | 4 million | 11/16/2017 | Citigroup, Cowen, Piper Jaffray |
| Artiva Biotherapeutics Inc. | ARTV | $14.00-$16.00 | 13.9 million | 7/19/2024 | Jefferies, TD Cowen, Cantor
|
| Arvinas, Inc | ARVN | $14.00-$16.00 | 7.5 million | 9/27/2018 | Goldman Sachs, Citigroup, Piper Jaffray |
| Ascendis Pharma A/S | ASND | $16.00-$18.00 | 6 million | 1/28/2015 | BofA Merrill Lynch, Leerink Partners, Wells Fargo Securities |
| ASLAN Pharmaceuticals Limited | ASLN | $8.05-$8.05 | 6 million ADSs | 5/4/2018 | Leerink Partners, Piper Jaffray |
| ATAI Life Sciences B.V. | ATAI | $13.00-$15.00 | 15 million | 6/18/2021 | Credit Suisse, Citigroup, Cowen, Berenberg |
| Atara Biotherapeutics, Inc. | ATRA | $14.00-$16.00 | 5 million | 10/16/2014 | Goldman Sachs & Co., Citigroup
|
| Atea Pharmaceuticals, Inc. | AVIR | $22.00-$24.00 | 12.5 million | 10/30/2020 | J.P. Morgan, Morgan Stanley, Evercore ISI, William Blair |
| Athenex, Inc. | ATNX | $11.00-$13.00 | 6 million | 6/14/2017 | Credit Suisse, Deutsche Bank Securities, J.P. Morgan |
| Athira Pharma, Inc. | ATHA | $15.00-$17.00 | 12 million | 9/18/2020 | Goldman Sachs, Jefferies, Stifel |
| Atreca Inc | BCEL | $16.00-$18.00 | 7.4 million | 6/20/2019 | Cowen, Evercore ISI, Stifel
|
| aTyr Pharma | LIFE | $13.00-$15.00 | 5.4 million | 5/7/2015 | J.P. Morgan, Citigroup
|
| Audentes Therapeutics, Inc. | BOLD | $14.00-$16.00 | 5 million | 7/20/2016 | BofA Merrill Lynch, Cowen & Co., Piper Jaffray |
| Auna S.A.A. | AUNA | $13.00-$15.00 | 30 million | 3/22/2024 | Morgan Stanley, JP Morgan, BTG Pactual, Santander, Citigroup, HSBC |
| Aura Biosciences, Inc. | AURA | $14.00-$16.00 | 5.4 million | 10/29/2021 | Cowen, SVB Leerink, Evercore |
| Auris Medical Holding AG | EARS | $10.00-$12.00 | 9.4 million | 8/6/2014 | Jefferies, Leerink Partners |
| Auspex Pharmaceuticals | ASPX | $10.00-$12.00 | 7 million | 2/5/2014 | Stifel, BMO Capital Markets |
| Autolus Therapeutics Limited | AUTL | $15.00-$17.00 | 8.8 million | 6/22/2018 | Goldman Sachs & Co., Jefferies |
| Avadim Health Inc. | AHI | $14.00-$16.00 | 5 million | 0/0/0 | Raymond James, SunTrust Robinson Humphrey |
| Avalanche Biotechnologies, Inc. | AAVL | $13.00-$15.00 | 5.4 million | 7/31/2014 | Jefferies, Cowen & Co., Piper Jaffray |
| Avantor, Inc. | AVTR | $18.00-$21.00 | 207 million | 5/17/2019 | Goldman Sachs, JP Morgan, BofA Merrill Lynch, Barclays, Jefferies |
| Aveanna Healthcare Holdings Inc. | AVAH | $12.00-$13.00 | 38.3 million | 4/29/2021 | Barclays, JP Morgan, BMO Capital, Credit Suisse, BofA Securities, Deutsche Bank, Jefferies, RBC Capital, Truist Securities |
| Avedro, Inc | AVDR | $14.00-$16.00 | 5 million | 2/14/2019 | BofA Merrill Lynch, JP Morgan, Cowen, Guggenheim Securities, SVB Leerink |
| Avenue Therapeutics, Inc. | ATXI | $5.00-$7.00 | 5.5 million | 6/27/2017 | Oppenheimer & Co. |
| AveXis, Inc. | AVXS | $19.00-$21.00 | 4.75 million | 2/11/2016 | Goldman Sachs & Co., Jefferies
|
| Avidity Biosciences, Inc. | RNA | $14.00-$16.00 | 14.4 million | 6/12/2020 | Cowen, SVB Leerink, Credit Suisse, Wells Fargo Securities |
| Avinger, Inc. | AVGR | $12.00-$14.00 | 5 million | 1/30/2015 | Canaccord Genuity, Cowen & Co.
|
| AVROBIO, Inc. | AVRO | $16.00-$18.00 | 5.2 million | 6/21/2018 | Morgan Stanley, Cowen, Wells Fargo Securities |
| Axcella Health Inc. | AXLA | $20.00-$22.00 | 3.6 million | 5/9/2019 | Goldman Sachs, JP Morgan, SVB Leerink |
| Axonics Modulation Technologies, Inc. | AXNX | $14.00-$16.00 | 8.0 million | 10/31/2018 | BofA Merrill Lynch, Morgan Stanley |
| Axovant Sciences, Ltd. | AXON | $13.00-$15.00 | 21 million | 6/11/2015 | Jefferies, Evercore ISI, RBC Capital Markets |
| Axsome Therapeutics | AXSM | $11.00-$13.00 | 5.6 million | 11/19/2015 | Ladenburg Thalmann |
| Ayala Pharmaceuticals, Inc. | AYLA | $14.00-$16.00 | 3.7 million | 5/8/2020 | Citigroup, Jefferies |
| Aziyo Biologics, Inc. | AZYO | $16.00-$18.00 | 2.9 million | 10/8/2020 | Piper Sandler, Cowen |
| AzurRx, Inc. | AZRX | $6.00-$8.00 | 960 thousand | 10/11/2016 | WallachBeth Capital, Network 1 Financial |
| Bausch + Lomb Corporation | BLCO | $21.00-$24.00 | 35 million | 5/6/2022 | Morgan Stanley, Goldman Sachs, Citigroup, JP Morgan, Barclays, BofA Securities, Guggenheim Securities, Jefferies, Evercore, Wells Fargo, Deutsche Bank |
| Beam Therapeutics, Inc. | BEAM | $15.00-$17.00 | 10.6 million | 2/6/2020 | JP Morgan, Jefferies, Barclays |
| BeiGene, Ltd. | BGNE | $15.00-$17.00 | 6.6 million | 2/3/2016 | Goldman Sachs & Co., Morgan Stanley, Cowen & Co. |
| Bellerophon Therapeutics | BLPH | $14.00-$16.00 | 4 million | 2/13/2015 | Leerink Partners, Cowen & Co. |
| Bellicum Pharmaceuticals | BLCM | $15.00-$17.00 | 7.35 million | 12/18/2014 | Jefferies, Citigroup, Piper Jaffray |
| Berkeley Lights, Inc. | BLI | $19.00-$20.00 | 8.1 million | 7/17/2020 | JP Morgan, Morgan Stanley, Cowen |
| BeyondSpring Inc. | BYSI | $20.00-$22.00 | 174K | 3/9/2017 | Rodman & Renshaw |
| Bicara Therapeutics, Inc. | BCAX | $16.00-$18.00 | 17.5 million | 9/13/2024 | Morgan Stanley, TD Cowen, Cantor, Stifel |
| Bicycle Therapeutics plc | BCYC | $14.00-$16.00 | 4.33 million | 5/23/2019 | Goldman Sachs, Jefferies, Piper Jaffray |
| Bind Therapeutics, Inc. | BIND | $14.00-$16.00 | 4.7 million | 9/20/2013 | Credit Suisse, Cowen & Co. |
| Bio Blast Pharma Ltd. | ORPN | $11.00-$13.00 | 3.2 million | 7/31/2014 | Oppenheimer & Co., Roth Capital Partners |
| BioAge Labs Inc. | BIOA | $17.00-$19.00 | 11 million | 9/26/2024 | Goldman Sachs, Morgan Stanley, Jefferies, Citigroup |
| BioAtla, Inc. | BCAB | $15.00-$17.00 | 10.5 million | 12/16/2020 | J.P. Morgan, Jefferies, Credit Suisse |
| Biodesix, Inc. | BDSX | $17.00-$19.00 | 4 million | 10/28/2020 | Morgan Stanley, William Blair
|
| Biofrontera AG | BFRA | $11.00-$13.00 | 1.21 million | 2/14/2018 | Benchmark |
| Biohaven Pharmaceutical Holding Company Ltd. | BHVN | $14.00-$16.00 | 9.9 million | 5/4/2017 | Morgan Stanley, Piper Jaffray, Barclays |
| Biomea Fusion, Inc. | BMEA | $15.00-$17.00 | 9 million | 4/16/2021 | JP Morgan, Jefferies, Piper Sandler
|
| Bionano Genomics, Inc. | BNGOU | $6.00-$7.00 | 3.36 million units | 8/21/2018 | Roth Capital, Maxim Group |
| BioNTech SE | BNTX | $18.00-$20.00 | 10 million ADSs | 10/10/2019 | JP Morgan, BofA Merrill Lynch, UBS Investment Bank, SVB Leerink |
| Bioventus Inc. | BVS | $16.00-$18.00 | 8 million | 2/11/2021 | Morgan Stanley, JP Morgan, Goldman Sachs |
| BioXcel Therapeutics, Inc. | BTAI | $11.00-$13.00 | 5.4 million | 3/8/2018 | Barclays, UBS Investment Bank, BMO Capital Markets
|
| Black Diamond Therapeutics, Inc. | BDTX | $16.00-$18.00 | 10.6 million | 1/30/2020 | JP Morgan, Jefferies, Cowen |
| bluebird bio, Inc. | BLUE | $14.00-$16.00 | 5.9 million | 6/19/2013 | J.P. Morgan, BofA Merrill Lynch
|
| Blueprint Medicines Corporation | BPMC | $15.00-$17.00 | 8.15 million | 4/30/2015 | Goldman Sachs & Co., Cowen & Co. |
| Bolt Therapeutics, Inc. | BOLT | $18.00-$19.00 | 11.5 million | 2/5/2021 | Morgan Stanley, SVB Leerink, Stifel, Guggenheim Securities |
| Boundless Bio Inc | BOLD | $15.00-$17.00 | 6.25 million | 3/28/2024 | Goldman Sachs, Leerink Partners, Piper Sandler, Guggenheim Securities |
| BridgeBio Pharma, Inc. | BBIO | $14.00-$16.00 | 20.5 million | 6/27/2019 | J.P. Morgan, Goldman Sachs & Co, Jefferies, SVB Leerink, KKR |
| Bright Health Group Inc. | BHG | $20.00-$23.00 | 51.35 million | 6/24/2021 | JP Morgan, Goldman Sachs, Morgan Stanley Barclays, BofA Securities, Citigroup, Piper Sandler |
| BrightSpring Health Services, Inc. | BTSG | $15.00-$18.00 | 53.3 million | 1/26/2024 | Goldman Sachs, KKR, Jefferies, Morgan Stanley, UBS, BofA Securities, Leerink Partners, Wells Fargo, Deutsche Bank, HSBC, Mizuho, BMO Capital Markets, Loop Capital Markets |
| Burning Rock Biotech Limited | BNR | $13.50-$15.50 | 13.5 million ADSs | 6/12/2020 | Morgan Stanley, BofA Securities, Cowen |
| C4 Therapeutics, Inc. | CCCC | $16.00-$18.00 | 9.6 million | 10/2/2020 | Jefferies, Evercore ISI, BMO Capital Markets, UBS Investment Bank
|
| Cabaletta Bio, Inc. | CABA | $14.00-$16.00 | 6.8 million | 10/25/2019 | Morgan Stanley, Cowen, Evercore ISI |
| Calithera Biosciences | CALA | $13.00-$15.00 | 8 million | 10/2/2014 | Citigroup, Leerink Partners |
| Calliditas Therapeutics AB | CALT | $19.77-$19.77 | 4.1 million ADSs | 6/5/2020 | Citigroup, Jefferies, Stifel |
| Calyxt, Inc. | CLXT | $15.00-$18.00 | 7 million | 7/20/2017 | Citigroup, Jefferies, Wells Fargo Securities |
| CAMP4 Therapeutics Corporation | CAMP | $14.00-$16.00 | 6.82 million | 10/11/2024 | J.P. Morgan, Leerink Partners, Piper Sandler, William Blair
|
| Cancer Genetics | CGIX | $10.00-$12.00 | 600 Thousand | 4/5/2013 | Aegis Capital Corp, Feltl & Co. |
| Cancer Prevention Pharmaceuticals | CPP | Withdrawn | 1.25 million | 0/0/0 | Aegis Capital |
| Candel Therapeutics, Inc. | CADL | $8.00-$8.00 | 9 million | 7/27/2021 | Jefferies, Credit Suisse, BMO Capital Markets, UBS Investment Bank |
| Candela Medical, Inc. | CDLA | Postponed | Postponed | 10/28/2021 | BofA Securities, Goldman Sachs, Barclays, Baird, Canaccord Genuity, Stifel |
| Capnia, Inc. | CAPN | $6.50-$8.50 | 1.65 million | 11/13/2014 | Maxim Group LLC |
| Cara Therapeutics | CARA | $11.00-$13.00 | 5 million | 1/31/2014 | Stifel, Piper Jaffray |
| Carbylan Therapeutics | CBYL | $12.00-$14.00 | 13 million | 4/9/2015 | Leerink Partners |
| Cardiva Medical Inc | TBD | Withdrawn | Withdrawn | 1/0/2021 | J.P. Morgan, BofA Securities, Canaccord Genuity, Stifel |
| CareDx Inc., | CDNA | $15.00-$17.00 | 4 million | 7/17/2014 | Piper Jaffray, Leerink Partners |
| CARGO Therapeutics, Inc. | CRGX | $15.00-$17.00 | 18.75 million | 11/10/2023 | J.P. Morgan, Jefferies, TD Cowen, Truist Securities |
| Caribou Biosciences, Inc. | CRBU | $14.00-$16.00 | 19 million | 7/23/2021 | BofA Securities, Citigroup, SVB Leerink
|
| Carmot Therapeutics Inc. | CRMO | Withdrawn | Withdrawn | 0/0/0 | J.P. Morgan, BofA Securities, Piper Sandler, Guggenheim |
| Castle Biosciences, Inc. | CSTL | $14.00-$16.00 | 4 million | 7/25/2019 | SVB Leerink, Baird |
| Castle Creek Biosciences, Inc. | CCBS | TBD | TBD | 0/0/0 | Citigroup, Piper Sandler, Barclays |
| Catabasis Pharmaceuticals | CATB | $13.00-$15.00 | 5 million | 6/25/2015 | Citigroup, Cowen & Co. |
| Catalent, Inc. | CTLT | $19.00-$22.00 | 42.5 million | 7/31/2014 | Morgan Stanley, J.P. Morgan |
| Celcuity LLC | CELC | $8.00-$10.00 | 2.4 million | 9/20/2017 | Craig Hallum Capital Group |
| Celladon Corporation | CLDN | $14.00-$16.00 | 5 million | 1/30/2013 | J.P. Morgan, Barclays |
| Cellular Dynamics International | ICEL | $12.00-$14.00 | 3.9 million | 7/25/2013 | J.P. Morgan |
| Cempra Holdings | CEMP | $11.00-$13.00 | 6 million | 2/3/2012 | Stifel Nicolaus Weisel, Leerink Swann, Cowen and Company |
| Centessa Pharmaceuticals plc. | CNTA | $18.00-$20.00 | 16.5 million ADSs | 5/28/2021 | Morgan Stanley, Goldman Sachs, Jefferies, Evercore ISI |
| Centogene N.V. | CNTG | $14.00-$16.00 | 4 million | 11/7/2019 | SVB Leerink, Evercore ISI |
| Centrexion Therapeutics Corporation | CNTX | Postponed | Postponed | 0/0/0 | BofA Merrill Lynch, Leerink Partners, Evercore ISI |
| Century Therapeutics, Inc | IPSC | $18.00-$20.00 | 10.6 million | 6/18/2021 | JP Morgan, BofA Securities, SVB Leerink, Piper Sandler |
| Cerecor, Inc. | CERC | $6.00-$7.00 | 4 million | 10/15/2015 | Maxim Group LLC |
| CeriBell, Inc. | CBLL | $14.00-$16.00 | 10.6 million | 10/11/2024 | BofA Securities, J.P. Morgan |
| Certara, Inc. | CERT | $19.00-$22.00 | 29.05 million | 12/11/2020 | Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays, William Blair |
| Cerulean Pharma | CERU | $11.00-$13.00 | 8.5 million | 4/10/2014 | Leerink Partners |
| CG Oncology, Inc. | CGON | $16.00-$18.00 | 20 million | 1/25/2024 | Morgan Stanley, Goldman Sachs, Cantor |
| Change Healthcare Inc. | CHNG | $16.00-$19.00 | 42.9 million | 6/27/2019 | Barclays, Goldman Sachs, JP Morgan, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Morgan Stanley. RBC Capital Markets |
| Check-Cap Ltd. | CHEKU | $10.00-$12.00 | 2 million | 2/19/2015 | Chardan Capital Markets, LLC, Maxim Group LLC
|
| Checkmate Pharmaceuticals, Inc. | CMPI | $14.00-$16.00 | 5 million | 8/7/2020 | BofA Securities, Jefferies, BMO Capital Markets |
| ChemoCentryx | CCXI | $14.00-$16.00 | 4.5 million | 2/23/2012 | J.P. Morgan, Citigroup |
| Chiasma, Inc. | CHMA | $13.00-$15.00 | 6.36 million | 7/16/2015 | Barclays, Cowen & Co. |
| Chimerix | CMRX | $13.00-$15.00 | 7.32 million | 4/11/2013 | Morgan Stanley, J.P. Morgan |
| Cibus Ltd. | CBUS | Postponed | Postponed | 0/0/0 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Cidara Therapeutics | CDTX | $14.00-$16.00 | 4.8 million | 4/15/2015 | Jefferies, Leerink Partners |
| CinCor Pharma, Inc. | CINC | $15.00-$17.00 | 12.1 million | 1/7/2022 | Morgan Stanley, Jefferies, Evercore ISI |
| Cirius Therapeutics, Inc. | CSTX | Withdrawn | Withdrawn | 0/0/0 | Citigroup, Credit Suisse |
| Civitas Solutions, Inc. | CIVI | $20.00-$23.00 | 11.7 million | 9/17/2014 | Barclays, Jefferies, BofA Merrill Lynch, UBS Investment Bank |
| Clearside Biomedical | CLSD | $7.00-$7.00 | 7.2 million | 6/2/2016 | Cowen & Co., Stifel |
| Clementia Pharmaceuticals | CMTA | $13.00-$15.00 | 8 million | 8/2/2017 | Morgan Stanley, Leerink Partners |
| Clovis Oncology | CLVS | $13.00-$15.00 | 9.3 million | 11/16/2011 | J.P. Morgan, Credit Suisse |
| Co-Diagnostics, Inc. | CODX | $6.35-$6.75 | 1.2 million | 7/12/2017 | WallachBeth Capital, LLC, Network 1 Financial Securities |
| Codex DNA, Inc. | DNAY | $14.00-$16.00 | 6.7 million | 6/18/2021 | Jefferies, Cowen, KeyBanc Capital
|
| Codiak BioSciences, Inc. | CDAK | $14.00-$16.00 | 5.5 million | 10/14/2020 | Goldman Sachs, Evercore ISI, William Blair |
| Cognition Therapeutics, Inc. | CGTX | $11.00-$13.00 | 3.77 million | 10/8/2021 | B Riley, Oppenheimer |
| Coherus BioSciences, Inc. | CHRS | $12.00-$15.00 | 6.3 million | 11/6/2014 | J.P. Morgan, Credit Suisse |
| Collegium Pharmaceutical | COLL | $12.00-$14.00 | 5.8 million | 5/7/2015 | Jefferies, Piper Jaffray |
| Colucid Pharmaceuticals | CLCD | $13.00-$15.00 | 5.5 million | 5/6/2015 | Piper Jaffray, Stifel |
| Community Healthcare Trust | CHCT | $19.00-$21.00 | 6.25 million | 5/21/2015 | Sandler O' Neill + Partners LP, Evercore ISI, SunTrust Robinson Humphrey |
| COMPASS Pathways plc | CMPS | $14.00-$16.00 | 7.5 million | 9/18/2020 | Cowen, Evercore ISI, Berenberg |
| Compass Therapeutics, Inc. | CMPX | Postponed | Postponed | 10/13/2020 | Citigroup, Credit Suisse, Stifel |
| Conatus Pharmaceuticals | CNAT | $10.00-$12.00 | 6 million | 7/25/2013 | Stifel Nicolaus Weisel, Piper Jaffray |
| Concentra Group Holdings Parent, Inc. | CON | $23.00-$26.00 | 22.5 million | 7/25/2024 | J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank, Wells Fargo Securities, Mizuho, RBC Capital, Truist |
| Concert Pharmaceuticals, Inc. | CNCE | $12.00-$14.00 | 6 million | 2/13/2014 | UBS Investment Bank, Wells Fargo Securities |
| ConforMIS, Inc. | CFMS | $14.00-$16.00 | 9 million | 7/1/2015 | J.P. Morgan, Deutsche Bank Securities |
| Connect Biopharma Holdings Limited | CNTB | $15.00-$17.00 | 11.25 million ADSs | 3/19/2021 | Jefferies, SVB Leerink, Piper Sandler, CICC |
| Constellation Pharmaceuticals, Inc. | CNST | $14.00-$16.00 | 4 million | 7/19/2018 | J.P. Morgan, Jefferies, BMO Capital Markets
|
| Contineum Therapeutics, Inc. | CTNM | $16.00-$18.00 | 6.875 million | 4/5/2024 | Goldman Sachs, Morgan Stanley, Stifel, RBC Capital |
| Convey Holding Parent, Inc. | CNVY | $14.00-$16.00 | 13.3 million | 6/16/2021 | Goldman Sachs, JP Morgan, Barclays
|
| Corium International, Inc. | CORI | $10.00-$12.00 | 6.5 million | 4/3/2014 | Jefferies, Leerink Partners |
| Cortexyme, Inc. | CRTX | $16.00-$18.00 | 4.4 million | 5/9/2019 | BofA Merrill Lynch, Credit Suisse |
| Corvus Pharmaceuticals | CRVS | $15.00-$17.00 | 4.7 million | 3/23/2016 | Credit Suisse, Cowen & Co., Guggenheim Securities |
| Crinetics Pharmaceuticals, Inc. | CRNX | $15.00-$17.00 | 6.0 million | 7/18/2018 | J.P. Morgan, Leerink Partners, Piper Jaffray |
| CRISPR Therapeutics | CRSP | $15.00-$17.00 | 4 million | 10/19/2016 | Citigroup, Piper Jaffray, Barclays |
| Cue Biopharma, Inc. | CUE | $7.50-$7.50 | 8.8 million | 1/2/2018 | MDB Capital, Feltl and Company |
| Cue Health Inc. | HLTH | $15.00-$17.00 | 12.5 million | 9/24/2021 | Goldman Sachs, Morgan Stanley, Cowen |
| Cullinan Management, Inc. | CGEM | $19.00-$20.00 | 11.9 million | 1/8/2021 | Morgan Stanley, SVB Leerink, Evercore ISI |
| CureVac B.V. | CVAC | $14.00-$16.00 | 13.3 million | 8/14/2020 | BofA Securities, Jefferies, Credit Suisse |
| CVRx, Inc. | CVRX | $15.00-$17.00 | 7 million | 6/30/2021 | JP Morgan, Piper Sandler, William Blair |
| Cyteir Therapeutics, Inc. | CYT | $16.00-$18.00 | 7.4 million | 6/18/2021 | JP Morgan, Morgan Stanley, BofA Securities |
| Cytek Biosciences, Inc. | CTKB | $16.00-$18.00 | 16.7 million | 7/23/2021 | Morgan Stanley, Goldman Sachs, Piper Sandler, Cowen
|
| CytomX Therapeutics | CTMX | $14.00-$16.00 | 6.7 million | 10/8/2015 | BofA Merrill Lynch, Jefferies, Cowen & Co. |
| Day One Biopharmaceuticals Holding Company, LLC | DAWN | $14.00-$16.00 | 10 million | 5/27/2021 | JP Morgan, Cowen, Piper Sandler |
| Decibel Therapeutics, Inc. | DBTX | $16.00-$18.00 | 7.062 million | 2/12/2021 | Citigroup, SVB Leerink, BMO Capital Markets, Barclays |
| Decipher Biosciences, Inc. | DECI | Withdrawn | Withdrawn | 0/0/0 | Evercore ISI, Wells Fargo |
| Deciphera Pharmaceuticals | DCPH | $15.00-$17.00 | 7.5 million | 9/28/2017 | J.P. Morgan, Piper Jaffray |
| Definitive Healthcare Corp | DH | $24.00-$26.00 | 15.6 million | 9/15/2021 | Goldman Sachs, J.P. Morgan, Morgan Stanley, Barclays, Credit Suisse, Deutsche Bank Securities |
| Denali Therapeutics Inc | DNLI | $17.00-$19.00 | 13.88 million | 12/8/2017 | Goldman Sachs, J.P. Morgan, Morgan Stanley |
| Dermavant Sciences, Inc. | DRMT | Postponed | Postponed | 6/20/2019 | Jefferies, SVB Leerink, Guggenheim Securities |
| Dermira, Inc. | DERM | $14.00-$16.00 | 7.8 million | 10/3/2014 | Citigroup, Leerink Partners
|
| Design Therapeutics, Inc | DSGN | $18.00-$20.00 | 12 million | 3/26/2021 | Goldman Sachs, SVB Leerink, Piper Sandler |
| Dicerna Pharmaceuticals, Inc. | DRNA | $11.00-$13.00 | 6 million | 1/30/2014 | Jefferies, Leerink Swann, Stifel |
| Dimension Therapeutics | DMTX | $14.00-$16.00 | 5.5 million | 10/22/2015 | Goldman Sachs & Co., Citigroup, Wells Fargo Securities
|
| Dipexium Pharmaceuticals, LLC | DPRX | $12.00-$14.00 | 2.75 million | 3/13/2014 | Oppenheimer & Co., Feltl & Co. |
| Diplomat Pharmacy | DPLO | $14.00-$16.00 | 13.33 million | 10/10/2014 | Credit Suisse, Morgan Stanley |
| Dova Pharmaceuticals, Inc. | DOVA | $15.00-$17.00 | 4.41 million | 6/29/2017 | J.P. Morgan, Jefferies, Leerink Partners |
| Doximity, Inc. | DOCS | $20.00-$23.00 | 23.3 million | 6/24/2021 | Morgan Stanley, Goldman Sachs, JP Morgan |
| Durata Therapeutics, Inc. | DRTX | $11.00-$13.00 | 7.5 million | 7/19/2012 | BofA Merrill Lynch, Credit Suisse |
| Dynacure S.A. | DYCU | Withdrawn | Withdrawn | 7/16/2021 | J.P. Morgan, BofA Securities, Wells Fargo Securities |
| Dyne Therapeutics Inc | DYN | $16.00-$18.00 | 12.25 million | 9/17/2020 | J.P. Morgan, Jefferies, Piper Sandler, Stifel |
| Eagle Pharmaceuticals | EGRX | $14.00-$16.00 | 3.33 million | 2/12/2014 | Piper Jaffray, William Blair |
| Eargo, Inc. | EAR | $14.00-$16.00 | 7.8 miliion | 10/16/2020 | J.P. Morgan, BofA Securities |
| Edge Therapeutics | EDGE | $14.00-$16.00 | 7.3 million | 10/1/2015 | Leerink Partners, Credit Suisse |
| Edgewise Therapeutics, Inc. | EWTX | $14.00-$16.00 | 11 million | 3/26/2021 | JP Morgan, Goldman Sachs, SVB Leerink |
| Editas Medicine, Inc. | EDIT | $16.00-$18.00 | 5.9 million | 2/3/2016 | Morgan Stanley, J.P. Morgan |
| Egalet | EGLT | $11.00-$13.00 | 4.2 million | 2/6/2014 | Stifel, JMP Securities |
| Eidos Therapeutics, Inc. | EIDX | $15.00-$17.00 | 6.3 million | 6/20/2018 | J.P. Morgan, BofA Merrill Lynch |
| Elanco Animal Health Inc. | ELAN | $20.00-$23.00 | 63 million | 9/20/2018 | Goldman Sachs, J.P. Morgan, Morgan Stanley |
| ElectroCore LLC | ECOR | $14.00-$16.00 | 4.33 million | 6/21/2018 | Evercore ISI, JMP Securities, BTIG |
| Elevation Oncology, Inc. | ELEV | $15.00-$17.00 | 6.25 million | 6/25/2021 | JP Morgan, Cowen, SVB Leerink
|
| Eleven Biotherapeutics | EBIO | $13.00-$15.00 | 5 million | 2/6/2014 | Citigroup, Cowen & Co., Leerink Swann |
| Eliem Therapeutics, Inc. | ELYM | $12.50-$12.50 | 6.4 million | 8/10/2021 | SVB Leerink, Evercore ISI, Stifel, Guggenheim Securities |
| Ellipse Technologies, Inc. | MGEC | TBD | TBD | 0/0/0 | Piper Jaffray, William Blair, Canaccord Genuity
|
| Enanta Pharmaceuticals | ENTA | $14.00-$16.00 | 4 million | 3/21/2013 | J.P. Morgan, Credit Suisse |
| EndoChoice Holdings | GI | $15.00-$17.00 | 6.35 million | 6/5/2015 | J.P. Morgan, BofA Merrill Lynch |
| Endostim, Inc. | STIM | TBD | 3.2 million | 0/0/0 | Wedbush PacGrow Life Sciences
|
| Endra Life Sciences | NDRAU | $5.00-$5.50 | 1.68 million | 5/9/2017 | National Securities, Dougherty & Company |
| Ensemble Health Partners, Inc. | ENSB | Postponed | Postponed | 10/28/2021 | Goldman Sachs, BofA Securities, Deutsche Bank, Guggenheim Securities, Credit Suisse, Evercore ISI, Wells Fargo Securities, SVB Leerink |
| Entasis Therapeutics Holdings Inc. | ETTX | $16.00-$18.00 | 5 million | 9/26/2018 | Credit Suisse, BMO Capital Markets |
| Entellus Medical | ENTL | $15.00-$17.00 | 4.6 million | 1/29/2015 | BofA Merrill Lynch, Piper Jaffray
|
| Entera Bio Ltd. | ENTX | $8.00-$10.00 | 1.3 million | 6/28/2018 | Maxim Group |
| Entrada Therapeutics, Inc. | TRDA | $19.00-$21.00 | 9.075 million | 10/29/2021 | Goldman Sachs, Cowen, Evercore ISI |
| Envision Healthcare Holdings | EVHC | $20.00-$23.00 | 42 million | 8/14/2013 | Barclays, BofA Merrill Lynch, Citigroup |
| Envista Holdings Corporation | NVST | $21.00-$24.00 | 26.8 million | 9/18/2019 | JP Morgan, Goldman Sachs, Morgan Stanley |
| Enzymotec Ltd. | ENZY | $16.00-$18.00 | 4.4 million | 9/27/2013 | BofA Merrill Lynch, Jefferies, Wells Fargo Securities |
| Epocrates, Inc. | EPOC | | | 0/0/0 | J.P. Morgan |
| Equillium, Inc. | EQ | $14.00-$16.00 | 4.7 million | 10/12/2018 | Jefferies, Leerink, Stifel |
| Erasca, Inc. | ERAS | $14.00-$16.00 | 18.75 million | 7/16/2021 | J.P. Morgan, Morgan Stanley, BofA Securities, Evercore ISI, Guggenheim Securities
|
| ERYTECH Pharma S.A. | ERYP | $23.00-$24.00 | 4.7 million ADSs | 11/10/2017 | Jefferies, Cowen, Oddo BHF |
| Esperion Therapeutics, Inc. | ESPR | $13.00-$15.00 | 5 million | 6/26/2013 | Credit Suisse, Citigroup |
| Establishment Labs Holdings Inc. | ESTA | $15.00-$17.00 | 3.7 million | 7/19/2018 | Jefferies, Cowen, BTIG |
| Eton Pharmaceuticals, Inc. | ETON | $6.00-$6.00 | 3.6 million | 11/14/2018 | National Securities |
| Evaxion Biotech A/S | EVAX | $10.00-$12.00 | 3 million | 2/5/2021 | Oppenheimer |
| Evelo Biosciences, Inc. | EVLO | $15.00-$17.00 | 5.3 million | 5/9/2018 | Morgan Stanley, Cowen, BMO Capital Markets |
| Everside Health Group, Inc. | EVSD | Withdrawn | Withdrawn | 0/0/0 | Morgan Stanley, JP Morgan, Goldman Sachs, BofA Securities, William Blair |
| Evoke Pharma | EVOK | $12.00-$14.00 | 2.1 million | 9/25/2013 | Aegis Capital Corp |
| Evolent Health | EVH | $14.00-$16.00 | 11.5 million | 6/5/2015 | J.P. Morgan, Goldman Sachs & Co. |
| Evolus, Inc. | EOLS | $12.00-$14.00 | 5 million | 2/8/2018 | Cantor, Mizuho Securities |
| Evotec SE | EVO | $26.16-$26.16 | 20 million ADSs | 11/4/2021 | BofA Securities, Morgan Stanley, Citigroup, Jefferies, Cowen, RBC Capital Markets |
| Exagen Diagnostics, Inc. | EXDX | TBD | TBD | 0/0/0 | Leerink Partners, Baird |
| Exagen Inc. | XGN | $14.00-$16.00 | 3.6 million | 9/19/2019 | Cowen, Cantor, William Blair |
| Exscientia Limited | EXAI | $20.00-$22.00 | 13.85 million | 10/1/2021 | Goldman Sachs, Morgan Stanley, BofA Securities, Barclays |
| Eyenovia, Inc. | EYEN | $10.00-$12.00 | 2.73 million | 1/25/2018 | Ladenburg Thalmann, Roth Capital Partners |
| Fate Therapeutics, Inc. | FATE | $6.00-$8.00 | 6.7 million | 10/1/2013 | Cowen & Co., BMO Capital Markets |
| FibroGen, Inc. | FGEN | $16.00-$19.00 | 8.1 million | 11/14/2014 | Goldman Sachs & Co., Citigroup, Leerink Partners
|
| Finch Therapeutics Group, Inc. | FNCH | $15.00-$17.00 | 7.5 million | 3/19/2021 | BofA Securities, Jefferies, Evercore ISI |
| Fireman B.V. | IFRX | $14.00-$16.00 | 6.67 million | 11/8/2017 | J.P. Morgan, Leerink Partners, BMO Capital Markets |
| Five Prime Therapeutics | FPRX | $12.00-$14.00 | 2.8 million | 9/18/2013 | Jefferies, BMO Capital Markets, Wells Fargo Securities |
| Flex Pharma | FLKS | $12.00-$14.00 | 5.4 million | 1/29/2015 | Jefferies, Piper Jaffray |
| Flexion Therapeutics, Inc. | FLXN | $12.00-$14.00 | 5 million | 2/12/2014 | BMO Capital Markets, Wells Fargo Securities |
| Foamix Pharmaceuticals | FOMX | $10.00-$12.00 | 6.7 million | 9/18/2014 | Barclays, Cowen and Company
|
| Foghorn Therapeutics Inc. | FHTX | $15.00-$17.00 | 7.5 million | 10/23/2020 | Goldman Sachs, Morgan Stanley, Cowen |
| Forma Therapeutics Holdings, Inc. | FMTX | $16.00-$18.00 | 13.8 million | 6/19/2020 | Jefferies, SVB Leerink, Credit Suisse |
| Forty Seven, Inc. | FTSV | $14.00-$16.00 | 7 million | 6/28/2018 | Morgan Stanley, Credit Suisse |
| Forward Pharma | FWP | $20.00-$22.00 | 10.5 million | 10/15/2014 | Leerink Partners, Jefferies, RBC Capital Markets
|
| Foundation Medicine | FMI | $14.00-$16.00 | 5.89 million | 9/25/2013 | Goldman Sachs, J.P. Morgan |
| Fractyl Health, Inc. | GUTS | $14.00-$16.00 | 7.33 million | 2/2/2024 | BofA Securities, Morgan Stanley, Evercore ISI |
| Freeline Therapeutics Holdings plc | FRLN | $16.00-$18.00 | 8.8 million ADSs | 8/7/2020 | JP Morgan, Morgan Stanley, Evercore |
| Frequency Therapeutics, Inc. | FREQ | $14.00-$16.00 | 6.0 million | 10/3/2019 | J.P. Morgan, Goldman Sachs, Cowen |
| Fulcrum Therapeutics, Inc. | FULC | $16.00-$18.00 | 4.5 million | 7/18/2019 | Morgan Stanley, BofA Merrill Lynch, SVB Leerink |
| Fulgent Genetics, Inc. | FLGT | $12.00-$14.00 | 4.2 million | 9/29/2016 | Credit Suisse, Piper Jaffray, Raymond James |
| Fusion Pharmaceuticals Inc. | FUSN | $14.00-$16.00 | 12.5 million | 6/26/2020 | Morgan Stanley, Jefferies, Cowen |
| G1 Therapeutics, Inc. | GTHX | $15.00-$17.00 | 7 million | 5/17/2017 | J.P. Morgan, Cowen and Company |
| Gain Therapeutics, Inc. | GANX | $10.00-$12.00 | 3.6 million | 3/18/2021 | BTIG, Oppenheimer |
| Galecto, Inc. | GLTO | $14.00-$16.00 | 5.7 million | 10/29/2020 | BofA Securities, SVB Leerink, Credit Suisse |
| Galera Therapeutics, Inc. | GRTX | $14.00-$16.00 | 5 million | 11/7/2019 | BofA Merrill Lynch, Citigroup, Credit Suisse |
| Gamida Cell Ltd. | GMDA | $13.00-$15.00 | 6.25 million | 10/26/2018 | BMO Capital, RBC Capital |
| Gemphire Therapeutics | GEMP | $11.00-$13.00 | 3 million | 8/5/2016 | Jefferies, RBC Capital Markets |
| Generation Bio Co. | GBIO | $16.00-$18.00 | 10.5 million | 6/12/2020 | JP Morgan, Jefferies, Cowen |
| Genetron Holdings Limited | GTH | $11.50-$13.50 | 16 million ADSs | 6/19/2020 | Credit Suisse, CICC |
| Genfit S.A. | GNFT | $26.33-$26.33 | 6.7 million ADSs | 3/27/2019 | SVB Leerink, Barclays |
| Genmab A/S | GMAB | $18.11-$18.11 | 28.5 million ADSs | 7/18/2019 | BofA Merrill Lynch, Morgan Stanley, Jefferies, Guggenheim Securities, RBC Capital |
| Genprex, Inc. | GNPX | $5.00-$5.00 | 1.3 million | 3/29/2018 | Network 1 Financial |
| GenSight Biologics S.A. | GNST | Withdrawn | | 11/6/2015 | Leerink Partners, Evercore ISI, Canaccord Genuity |
| GH Research PLC | GHRS | $14.00-$16.00 | 10 million | 6/25/2021 | Cowen, Stifel |
| Glaukos Corporation | GKOS | $13.00-$15.00 | 6 million | 6/25/2015 | J.P. Morgan, BofA Merrill Lynch, Goldman Sachs & Co. |
| Global Blood Therapeutics | GBT | $16.00-$18.00 | 6 million | 8/12/2015 | Morgan Stanley, Goldman Sachs & Co. |
| Globus Medical | GMED | $16.00-$18.00 | 8.33 million | 8/3/2012 | BofA Merrill Lynch, Goldman Sachs, Piper Jaffray |
| GlycoMimetics | GLYC | $14.00-$16.00 | 7.0 million | 1/10/2014 | Jefferies, Barclays |
| GoHealth, Inc. | GOCO | $18.00-$20.00 | 43.5 million | 7/15/2020 | Goldman Sachs, BofA Securities, Morgan Stanley, Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair |
| GoodRx Holdings, Inc. | GDRX | $24.00-$28.00 | 34.6 million | 9/23/2020 | Morgan Stanley, Goldman Sachs, J.P. Morgan, Barclays, BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI
|
| Gossamer Bio, Inc. | GOSS | $16.00-$16.00 | 17.25 million | 2/8/2019 | BofA Merrill Lynch, Leerink, Barclays, Evercore ISI |
| Gracell Biotechnologies Inc. | GRCL | $16.00-$18.00 | 11 million | 1/8/2021 | Citigroup, Jefferies, Piper Sandler, Wells Fargo |
| GRAIL, Inc. | GRAL | Withdrawn | Withdrawn | 0/0/0 | Morgan Stanley, Goldman Sachs, BofA Securities, Cowen, Evercore ISI
|
| Graphite Bio, Inc. | GRPH | $15.00-$17.00 | 14 million | 6/25/2021 | Morgan Stanley, BofA Securities, Cowen, SVB Leerink |
| Graybug Vision, Inc. | GRAY | $15.00-$17.00 | 5.625 million | 9/25/2020 | SVB Leerink, Piper Sandler |
| Greenlane Holdings, Inc. | GNLN | $14.00-$16.00 | 6 million | 4/18/2019 | Cowen, Canaccord Genuity |
| Gritstone Oncology, Inc. | GRTS | $13.00-$15.00 | 6.7 million | 9/28/2018 | Goldman Sachs, Cowen, Barclays |
| Guardant Health, Inc. | GH | $15.00-$17.00 | 12.5 million | 10/4/2018 | JP Morgan, BofA Merrill Lynch |
| Guardian Pharmacy Services, Inc. | GRDN | 8 million | $14.00-$16.00 | 9/26/2024 | Raymond James, Stephens Inc., Truist Securities |
| Gyroscope Therapeutics Holdings plc | VISN | Postponed | Postponed | 5/7/2021 | Morgan Stanley, Goldman Sachs, Citigroup
|
| Hancock Jaffe Laboratories, Inc. | HJLI | $6.00-$8.00 | 1.5 million | 5/31/2018 | Network 1 Financial |
| Harmony Biosciences Holdings, Inc. | HRMY | $20.00-$23.00 | 5.3 million | 8/19/2020 | Goldman Sachs, Jefferies, Piper Sandler
|
| Harpoon Therapeutics, Inc. | HARP | $13.00-$15.00 | 5.4 million | 2/8/2019 | Citigroup, SVB Leerink |
| Health Catalyst, Inc. | HCAT | $20.00-$23.00 | 7 million | 7/25/2019 | Goldman Sachs & Co., J.P. Morgan, William Blair |
| Healthcare Royalty, Inc | HCRX | Postponed | Postponed | 8/6/2021 | Goldman Sachs, Citigroup, Credit Suisse, Jefferies, Cowen, SVB Leerink |
| hear.com N.V. | HCG | Postponed | Postponed | 5/14/2021 | Morgan Stanley, JP Morgan, Deutsche Bank, Goldman Sachs |
| Heat Biologics | HTBX | $10.00-$12.00 | 2.5 million | 7/24/2013 | Aegis Capital Corp |
| HilleVax, Inc. | HLVX | $16.00-$18.00 | 11.8 million | 4/29/2022 | J.P. Morgan, SVB Leerink, Stifel, Guggenheim Securites |
| Histogenics Corporation | HSGX | $13.00-$15.00 | 5.91 million | 12/3/2014 | Cowen & Co., Needham & Co., Canaccord Genuity |
| Homology Medicines, Inc. | FIXX | $14.00-$16.00 | 9 million | 3/28/2018 | BofA Merrill Lynch, Cowen, Evercore ISI |
| HOOKIPA Pharma Inc. | HOOK | $14.00-$16.00 | 6 million | 4/18/2019 | BofA Merrill Lynch, SVB Leerink , RBC Capital |
| HTG Molecular Diagnostics | HTGM | $13.00-$15.00 | 3.6 million | 5/6/2015 | Leerink Partners |
| Hyperion Therapeutics, Inc | HPTX | $11.00-$13.00 | 5 million | 7/26/2012 | Leerink, Cowen & Company |
| I-Mab | IMAB | $12.00-$15.00 | 7.4 million ADSs | 1/17/2020 | Jefferies, CICC |
| IASIS Healthcare Corporation | IAS | TBD | TBD | 0/0/0 | BofA Merrill Lynch, Barclays, J.P. Morgan |
| Icosavax, Inc. | ICVX | $14.00-$16.00 | 12.1 million | 7/29/2021 | Jefferies, Cowen, Evercore ISI, William Blair |
| IDEAYA Biosciences, Inc. | IDYA | $13.00-$15.00 | 5 million | 5/23/2019 | JP Morgan, Citigroup, Jefferies |
| IGM Biosciences, Inc. | IGMS | $15.00-$17.00 | 10.9 million | 9/18/2019 | Jefferies, Piper Jaffray, Stifel, Guggenheim Securities |
| iKang Healthcare Group, Inc. | KANG | $12.00-$14.00 | 10.9 million | 4/9/2014 | BofA Merrill Lynch, UBS Investment Bank |
| Ikena Oncology, Inc. | IKNA | $15.00-$17.00 | 7.8 million | 3/26/2021 | Jefferies, Cowen, Credit Suisse, William Blair |
| Imago BioSciences, Inc. | IMGO | $14.00-$16.00 | 8.4 million | 7/16/2021 | Jefferies, Cowen, Stifel, Guggenheim Securities |
| Imara Inc | IMRA | $16.00-$18.00 | 4.7 million | 3/12/2020 | Morgan Stanley, Citigroup, SVB Leerink |
| Immune Design Corp | IMDZ | $12.00-$14.00 | 5 million | 7/24/2014 | Jefferies, Leerink Partners, Wells Fargo Securities |
| Immuneering Corporation | IMRX | $14.00-$16.00 | 7.5 million | 7/30/2021 | Morgan Stanley, Jefferies, Cowen, Guggenheim Securities
|
| Immunocore Holdings plc | IMCR | $23.00-$25.00 | 9.9 million ADSs | 2/5/2021 | Goldman Sachs, JP Morgan, Jefferies
|
| Immunome Inc. | IMNM | $11.00-$13.00 | 3.25 million | 10/2/2020 | Ladenburg Thalmann, Chardan |
| Impel NeuroPharma, Inc. | IMPL | $14.00-$16.00 | 5.33 million | 4/23/2021 | Cowen, Guggenheim |
| IN8bio, Inc. | INAB | $10.00-$12.00 | 4 million | 7/30/2021 | B. Riley Securities |
| Inari Medical, Inc. | NARI | $14.00-$16.00 | 8.2 million | 5/22/2020 | BofA Securities, Morgan Stanley |
| INC Research Holdings, Inc. | INCR | $17.00-$20.00 | 8.1 million | 11/7/2014 | Goldman Sachs, Credit Suisse |
| Inhibrx, Inc. | INBX | $16.00-$18.00 | 7 million | 8/19/2020 | Jefferies, Evercore ISI, Credit Suisse |
| InMode Ltd. | INMD | $14.00-$16.00 | 5 million | 8/8/2019 | Barclays, UBS Investment Bank, Canaccord Genuity |
| Innate Pharma S.A | IPHA | $7.50-$7.50 | 12.5 million ADSs | 10/17/2019 | Citigroup, SVB Leerink, Evercore ISI |
| Innocoll GmbH | INNL | $13.00-$15.00 | 6.3 million | 7/25/2014 | Piper Jaffray, Stifel |
| InnovAge Holding Corp | INNV | $20.00-$21.00 | 16.7 million | 3/4/2021 | JP Morgan, Barclays, Goldman Sachs, Citigroup |
| Inogen, Inc. | INGN | $16.00-$18.00 | 4.4 million | 2/14/2014 | J.P. Morgan |
| Inotek Pharmaceuticals Corporation | ITEK | $13.00-$15.00 | 6.67 million | 2/18/2015 | Cowen & Co., Piper Jaffray
|
| Inozyme Pharma, Inc. | INZY | $16.00-$16.00 | 7 million | 7/24/2020 | BofA Securities, Cowen, Piper Sandler |
| Inspire Medical Systems, Inc. | INSP | $14.00-$16.00 | 6.75 million | 5/3/2018 | BofA Merrill Lynch, Goldman Sachs & Co. |
| Instil Bio, Inc. | TIL | $19.00-$20.00 | 16 million | 3/19/2021 | Morgan Stanley, Jefferies, Cowen |
| Insys Therapeutics, Inc. | INSY | $16.00-$18.00 | 4 million | 5/2/2013 | Wells Fargo Securities, JMP Securities |
| Intellia Therapeutics | NTLA | Priced at $18.00 | 6 million | 5/6/2016 | Credit Suisse, Jefferies, Leerink Partners |
| Intercept Pharmaceuticals | ICPT | $13.00-$15.00 | 5 million | 10/11/2012 | BofA Merrill Lynch, Citigroup, Goldman Sachs |
| Intersect ENT, Inc. | XENT | $11.00-$13.00 | 5 milion | 7/24/2014 | J.P. Morgan, Piper Jaffray |
| Intrexon | XON | $14.00-$16.00 | 10 million | 8/8/2013 | J.P. Morgan, Barclays Capital |
| Intuity Medical, Inc. | POGO | TBD | TBD | 0/0/0 | Goldman Sachs, Jefferies, Piper Sandler |
| Invea Therapeutics, Inc. | INAI | Withdrawn | Withdrawn | 0/0/0 | BofA Securities, Citigroup, Truist Securities |
| inVentiv Group Holdings | INV | Withdrawn | Withdrawn | 0/0/0 | Credit Suisse, Morgan Stanley, Goldman Sachs & Co., Jefferies |
| Inventiva S.A | IVA | $13.40-$15.40 | 7.48 million ADSs | 7/10/2020 | Jefferies, Stifel, Guggenheim Securities |
| Invitae Corporation | NVTA | $13.00-$15.00 | 6.35 million | 2/12/2015 | J.P. Morgan |
| Invuity, Inc. | IVTY | $14.00-$16.00 | 4 million | 6/15/2015 | Piper Jaffray, Leerink Partners, Stifel |
| IO Biotech, Inc. | IOBT | $14.00-$17.00 | 7.15 million | 11/5/2021 | Morgan Stanley, Jefferies, Cowen |
| iRadimed Inc. | IRMD | $5.00-$6.00 | 2.02 million | 7/16/2014 | Roth Capital Partners |
| IsoPlexis Corporation | ISO | $14.00-$16.00 | 8.33 million | 10/8/2021 | Morgan Stanley, Cowen, Evercore, SVB Leerink
|
| iTeos Therapeutics, Inc. | ITOS | $16.00-$18.00 | 10.6 million | 7/24/2020 | JP Morgan, SVB Leerink, Piper Sandler |
| Iterum Therapeutics plc | ITRM | $14.00-$16.00 | 6.2 million | 5/25/2018 | Leerink Partners, RBC Capital Partners |
| Jaguar Animal Health | JAGX | $7.00-$9.00 | 2.86 million | 5/13/2015 | Aegis Capital Corp |
| Janux Therapeutics, Inc. | JANX | $15.00-$17.00 | 11.4 million | 6/11/2021 | BofA Securities, Cowen, Evercore ISI |
| Jounce Therapeutics | JNCE | $13.00-$15.00 | 6.365 million | 1/27/2017 | J.P. Morgan, Cowen and Company |
| Journey Medical Corporation | DERM | $10.00-$12.00 | 3.5 million | 11/12/2021 | B. Riley Securities |
| Juno Therapeutics | JUNO | $15.00-$18.00 | 11.02 million | 12/19/2014 | Morgan Stanley, J.P. Morgan, Goldman Sachs & Co. |
| K2M Group Holdings, Inc. | KTWO | $16.00-$18.00 | 8.83 million | 5/8/2014 | Piper Jaffray, Barclays, Wells Fargo Securities
|
| Kadmon Holdings, LLC | KDMN | $16.00-$20.00 | 6.25 million | 7/27/2016 | Citigroup, Jefferies |
| Kala Pharmaceuticals, Inc. | KALA | $14.00-$16.00 | 6 million | 7/20/2017 | J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities |
| Kaleido Biosciences, Inc. | KLDO | $20.00-$22.00 | 5 million | 2/28/2019 | Goldman Sachs, J.P. Morgan, Morgan Stanley |
| KaloBios Pharmaceuticals | KBIO | $12.00-$14.00 | 8.75 million | 1/31/2013 | Leerink Swann |
| Karuna Therapeutics, Inc | KRTX | $15.00-$17.00 | 5.6 million | 6/28/2019 | Goldman Sachs, Citigroup, Wells Fargo |
| Karyopharm Therapeutics | KPTI | $14.00-$16.00 | 5.7 million | 11/6/2013 | BofA Merrill Lynch, J.P. Morgan, Leerink Partners |
| KCI Holdings, Inc. | TBD | Withdrawn | Withdrawn | 0/0/0 | JP Morgan, Goldman Sachs, BofA Merrill Lynch |
| KemPharm, Inc. | KMPH | $12.00-$14.00 | 5.09 million | 4/16/2015 | Cowen & Co., RBC Capital Markets |
| Kenvue Inc. | KVUE | $20.00-$23.00 | 172.8 million | 5/4/2023 | Goldman Sachs, JP Morgan, BofA Securities, Citigroup, Deutsche Bank, BNP PARIBAS, HSBC, RBC Capital Markets, UBS Investment Bank |
| Keros Therapeutics, Inc. | KROS | $14.00-$16.00 | 6 million | 4/8/2020 | Jefferies, SVB Leerink, Piper Sandler |
| Kezar Life Sciences, Inc. | KZR | $14.00-$16.00 | 5 million | 6/21/2018 | Jefferies, Cowen, Wells Fargo, William Blair |
| Kindred Biosciences, Inc. | KIN | $6.00-$8.00 | 7.5 million | 12/12/2014 | Leerink Partners, BMO Capital Markets, Guggenheim Securities |
| Kiniksa Pharmaceuticals, Ltd. | KNSA | $17.00-$19.00 | 8.5 million | 5/24/2018 | Goldman Sachs, J.P. Morgan |
| Kinnate Biopharma Inc. | KNTE | $18.00-$19.00 | 12 million | 12/3/2020 | Goldman Sachs, SVB Leerink , Piper Sandler |
| Kite Pharma, Inc., | KITE | $15.00-$16.00 | 7.5 million | 6/20/2014 | Jefferies, Credit Suisse, Cowen and Co. |
| Kodiak Sciences Inc. | KOD | $13.00-$15.00 | 9 million | 10/4/2018 | Morgan Stanley, BofA Merrill Lynch |
| Kronos Bio, Inc. | KRON | $16.00-$18.00 | 13.2 million | 10/9/2020 | Goldman Sachs, Jefferies, Cowen, Piper Sandler |
| Krystal Biotech, Inc. | KRYS | $9.00-$11.00 | 3.96 million | 9/20/2017 | Ladenburg Thalmann |
| Kymera Therapeutics, Inc. | KYMR | $16.00-$18.00 | 8.7 million | 8/21/2020 | Morgan Stanley, BofA Securities, Cowen, Guggenheim Securities |
| Kythera Biopharmaceuticals, Inc. | KYTH | $14.00-$16.00 | 5.1 million | 10/11/2012 | J.P. Morgan, Goldman Sachs & Co.
|
| Kyverna Therapeutics Inc. | KYTX | $20.00-$21.00 | 14.5 million | 2/8/2024 | JP Morgan, Morgan Stanley, Leerink Partners, Wells Fargo |
| Landos Biopharma, Inc. | LABP | $15.00-$17.00 | 6.25 million | 2/4/2021 | JP Morgan, Jefferies, SVB Leerink |
| Lantheus Holdings | LNTH | $8.50-$10.50 | 10.83 million | 6/25/2015 | Credit Suisse, Jefferies, RBC Capital Markets, Wells Fargo Securities |
| Lava Therapeutics B.V. | LVTX | $14.00-$16.00 | 6.7 million | 3/25/2021 | JP Morgan, Jefferies, SVB Leerink |
| LDR Holding | LDRH | $14.00-$16.00 | 5 million | 10/9/2013 | Piper Jaffray, William Blair |
| Legend Biotech Corporation | LEGN | $18.00-$20.00 | 18.4 million | 6/5/2020 | Morgan Stanley, JP Morgan, Jefferies |
| Lexeo Therapeutics, Inc. | LXEO | $13.00-$15.00 | 9.1 million | 11/3/2023 | J.P. Morgan, Leerink Partners, Stifel, RBC Capital Markets |
| LianBio | LIAN | $15.00-$17.00 | 20.3 million ADSs | 11/1/2021 | Goldman Sachs, Jefferies, BofA Securities |
| LifeStance Health Group, Inc. | LFST | $15.00-$17.00 | 40 million | 6/10/2021 | Morgan Stanley, Goldman Sachs, JP Morgan, Jefferies, TPG Capital BD, UBS Investment Bank, William Blair
|
| LinkDoc Technology Limited | LDOC | Postponed | Postponed | 7/9/2021 | Morgan Stanley, BofA Securities, CICC |
| Liposcience, Inc. | LPDX | $13.00-$15.00 | 5 million | 1/25/2013 | Barclays Capital, UBS Investment Bank, Piper Jaffray |
| Liquidia Technologies, Inc. | LQDA | $10.00-$12.00 | 4.54 million | 7/26/2018 | Jefferies, Cowen |
| LogicBio Therapeutics, Inc. | LOGC | $12.00-$14.00 | 7 million | 10/19/2018 | Jefferies, Barclays, William Blair, Chardan |
| Longboard Pharmaceuticals, Inc. | LBPH | $14.00-$16.00 | 5 million | 3/12/2021 | Citigroup, Evercore ISI, Guggenheim Securities, Cantor |
| Loxo Oncology, Inc. | LOXO | $12.00-$14.00 | 5.3 million | 8/1/2014 | Cowen & Co., Stifel |
| Lucid Diagnostics, Inc. | LUCD | $14.00-$16.00 | 5 million | 10/14/2021 | Cantor, Canaccord Genuity |
| Lucira Health, Inc. | LHDX | $15.00-$17.00 | 9 million | 2/5/2021 | BofA Securities, William Blair |
| Lumenis Ltd. | LMNS | $15.00-$17.00 | 6.25 million | 2/27/2014 | Goldman Sachs, Credit Suisse, Jefferies |
| LumiraDx Limited | LMDX | Withdrawn | Withdrawn | 0/0/0 | Jefferies, SVB Leerink, Evercore ISI, Raymond James
|
| Lyell Immunopharma, Inc. | LYEL | $16.00-$18.00 | 25 million | 6/17/2021 | Goldman Sachs, BofA Securities, JP Morgan, Morgan Stanley |
| Lyra Therapeutics, Inc. | LYRA | $14.00-$16.00 | 3.5 million | 5/1/2020 | BofA Securities, Jefferies, William Blair |
| Macrocure Ltd. | MCUR | $13.00-$15.00 | 5.4 million | 7/31/2014 | Credit Suisse, Jefferies |
| MacroGenics, Inc. | MGNX | $14.00-$16.00 | 5 million | 10/10/2013 | BofA Merrill Lynch, Leerink Swann |
| Magenta Therapeutics, Inc. | MGTA | $14.00-$16.00 | 6.7 million | 6/21/2018 | J.P. Morgan, Goldman Sachs, Cowen |
| Mainz Biomed B.V. | MYNZ | $4.00-$6.00 | 2 million | 11/4/2021 | Boustead Securities, LLC |
| Maravai LifeSciences Holdings, Inc. | MRVI | $24.00-$27.00 | 60 million | 11/20/2020 | Morgan Stanley, Jefferies, Goldman Sachs, BofA Securities, Credit Suisse, UBS Investment Bank, Baird, William Blair, Stifel, KeyBanc Capital |
| Marinus Pharmaceuticals | MRNS | $12.00-$14.00 | 5.62 million | 7/31/2014 | Stifel, JMP Securities |
| MaxCyte Inc. | MXCT | $11.50-$13.50 | 13.5 million | 7/30/2021 | Cowen, Stifel, William Blair |
| MBX Biosciences, Inc. | MBX | $14.00-$16.00 | 10.2 million | 9/13/2024 | J.P. Morgan, Jefferies, Stifel, Guggenheim Securities |
| MDxHealth, Inc. | MDXH | $13.46-$13.46 | 3.75 million ADSs | 11/4/2021 | Piper Sandler, Oppenheimer & Co. |
| Mediwound Ltd. | MDWD | $14.00-$16.00 | 5 million | 3/20/2014 | Credit Suisse, Jefferies, BMO Capital Markets |
| MedPace Holdings | MEDP | $20.00-$23.00 | 7 million | 8/11/2016 | Jefferies, Credit Suisse, UBS Investment Bank, Wells Fargo Securities |
| MeiraGTx Holdings plc | MGTX | $14.00-$16.00 | 5 million | 6/8/2018 | BofA Merrill Lynch, Barclays, Evercore ISI |
| Menlo Therapeutics, Inc. | MNLO | $14.00-$16.00 | 7 million | 1/25/2018 | Jefferies, Piper Jaffray, Guggenheim Securities |
| Mereo Biopharma Group plc | MREO | Postponed | Postponed | 0/0/0 | Cowen, BMO, RBC Capital |
| Merrimack Pharmaceuticals | MACK | $8.00-$10.00 | 14.3 million | 3/29/2012 | J.P. Morgan, BofA Merrill Lynch |
| Mersana Therapeutics, Inc. | MRSN | $14.00-$16.00 | 5 million | 6/28/2017 | J.P. Morgan, Cowen and Company, Leerink Partners |
| Merus B.V. | MRUS | $14.00-$16.00 | 5.5 million | 5/19/2016 | Citigroup, Jefferies |
| Metacrine, Inc. | MTCR | $12.00-$14.00 | 6.5 million | 9/16/2020 | Jefferies, Evercore ISI, RBC Capital Markets |
| Metagenomi, Inc. | MGX | $15.00-$17.00 | 6.25 million | 2/9/2024 | J.P. Morgan, Jefferies, TD Cowen, Wells Fargo Securities, BMO Capital Markets |
| Milestone Pharmaceuticals Inc. | MIST | $14.00-$16.00 | 5.5 million | 5/9/2019 | Jefferies, Cowen, Piper Jaffray, Oppenheimer & Co. |
| Mineralys Therapeutics, Inc. | MLYS | $14.00-$16.00 | 12 million | 2/10/2023 | BofA Securities, Evercore ISI, Stifel, Guggenheim Securities, Credit Suisse, Wells Fargo |
| Minerva Neurosciences | NERV | $10.00-$12.00 | 5.5 million | 7/1/2014 | Jefferies |
| Minerva Surgical, Inc | UTRS | $15.00-$17.00 | 6.25 million | 10/22/2021 | J.P. Morgan, Piper Sandler, UBS Investment Bank, SVB Leerink |
| MiNK Therapeutics, Inc. | INKT | $12.00-$14.00 | 3.33 million | 10/15/2021 | Evercore ISI, William Blair |
| Mirna Therapeutics | MIRN | $13.00-$15.00 | 6.25 million | 10/1/2015 | Citigroup, Leerink Partners |
| Miromatrix Medical, Inc | MIRO | $7.00-$9.00 | 4.8 million | 6/24/2021 | Craig Hallum |
| Mirum Pharmaceuticals, Inc. | MIRM | $14.00-$16.00 | 5 million | 7/18/2019 | Citigroup, Evercore ISI, Guggenheim Securities |
| Moderna, Inc. | MRNA | $22.00-$24.00 | 26 million | 12/7/2018 | Morgan Stanley, Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch, Barclays, Piper Jaffray |
| Molecular Partners Inc. | MOLN | $27.14-$27.14 | 3 million ADSs | 6/16/2021 | JP Morgan, SVB Leerink, Cowen, RBC Capital
|
| Moleculin Biotech, Inc. | MBRX | $5.00-$6.00 | 1.54 million | 6/2/2016 | Bonwick Capital Partners LLC, Network 1 Financial Securities |
| Monte Rosa Therapeutics Inc. | GLUE | $17.00-$19.00 | 11.7 million | 6/24/2021 | JP Morgan, Cowen, Piper Sandler, Guggenheim |
| Morphic Holding, Inc. | MORF | $14.00-$16.00 | 6 million | 6/27/2019 | Jefferies, Cowen, BMO Capital Markets, Wells Fargo Securities |
| MorphoSys AG | MOR | $24.12-$24.12 | 8.3 million ADSs | 4/19/2018 | Goldman Sachs & Co., J.P. Morgan, Leerink Partners |
| Motus GI Holdings, Inc. | MOTS | $5.00-$7.00 | 3.5 million | 2/14/2018 | Piper Jaffray, Oppenheimer & Co. |
| MyoKardia, Inc. | MYOK | $15.00-$17.00 | 5.4 million | 10/29/2015 | Credit Suisse, Cowen & Co. |
| Myovant Sciences, Ltd. | MYOV | $12.00-$15.00 | 14.5 million | 10/27/2016 | Citigroup, Cowen and Company, Evercore ISI, Barclays |
| Nabriva Therapeutics AG | NBRV | $10.50-$10.50 | 9 million | 9/18/2015 | Leerink Partners, RBC Capital Markets |
| Nalu Medical, Inc. | NALU | TBD | TBD | 0/0/0 | JP Morgan, BofA Securities, William Blair |
| Nano-X Imaging Ltd. | NNOX | $16.00-$18.00 | 9.2 million | 8/21/2020 | Cantor, Oppenheimer & Co., Berenberg, CIBC Capital Markets
|
| NanoString Technologies | NSTG | $13.00-$15.00 | 5.4 million | 6/26/2013 | J.P. Morgan, Morgan Stanley |
| Nant Health | NH | $12.50-$15.50 | 6.5 million | 6/2/2016 | Jefferies, Cowen & Co. |
| NantKwest | NK | $20.00-$23.00 | 8.3 million | 7/28/2015 | BofA Merrill Lynch, Citigroup, Jefferies, Piper Jaffray |
| Natera, Inc. | NTRA | $15.00-$17.00 | 10 million | 7/2/2015 | Morgan Stanley, Cowen & Co., Piper Jaffray |
| Neon Therapeutics | NTGN | $15.00-$17.00 | 6.3 million | 6/27/2018 | Morgan Stanley, BofA Merrill Lynch, Mizuho Securities |
| Neos Therapeutics | NEOS | $14.00-$16.00 | 4.8 million | 7/23/2015 | UBS Investment Bank, BMO Capital Markets, RBC Capital Markets
|
| Neothetics, Inc. | NEOT | $13.00-$15.00 | 4.65 million | 11/20/2014 | Piper Jaffray, Guggenheim Securities
|
| Neumora Therapeutics, Inc.. | NMRA | $16.00-$18.00 | 14.7 million | 9/15/2023 | J.P. Morgan, BofA Securities, Stifel, Guggenheim, RBC Capital, William Blair
|
| Neuroderm, Ltd. | NDRM | $13.00-$16.00 | 4.5 million | 11/14/2014 | Jefferies, Cowen & Co. |
| Neuronetics, Inc. | STIM | $14.00-$16.00 | 5.5 million | 6/28/2018 | Piper Jaffray, William Blair |
| Neuropace Inc | NPCE | $15.00-$17.00 | 6 million | 4/22/2021 | JP Morgan, Morgan Stanley, Wells Fargo, SVB Leerink |
| Nevro | NVRO | $15.00-$17.00 | 7 million | 11/6/2014 | J.P. Morgan, Morgan Stanley |
| NewLink Genetics | NLNK | Last trade $11.40 | 3.5 million | 1/30/2013 | Jefferies, Stifel Nicolaus Weisel |
| NexImmune, Inc. | NEXI | $15.00-$17.00 | 6.5 million | 2/12/2021 | Barclays, Cantor, Raymond James, Allen & Co. |
| NextCure, Inc. | NXTC | $14.00-$16.00 | 5 million | 5/9/2019 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Nexvet Biopharma plc | NVET | $13.00-$16.00 | 4 million | 2/5/2015 | BofA Merrill Lynch, Cowen & Co. |
| NGM Biopharmaceuticals, Inc. | NGM | $14.00-$16.00 | 6.67 million | 4/4/2019 | Goldman Sachs, Citigroup, Cowen |
| Nightstar Therapeutics Limited | NITE | $13.00-$15.00 | 5.36 million ADSs | 9/28/2017 | Jefferies, Leerink Partners, BMO Capital Markets |
| Nivalis Therapeutics | NVLS | $13.00-$15.00 | 5.5 million | 6/17/2015 | Cowen & Co., Stifel |
| Nkarta, Inc. | NKTX | $16.00-$17.00 | 14 million | 7/10/2020 | Cowen, Evercore, Stifel, Mizuho |
| Novan, Inc. | NOVN | $11.00-$13.00 | 4.1 million | 9/21/2016 | Piper Jaffray |
| NovoCure Limited | NVCR | $26.00-$29.00 | 7.5 million | 10/2/2015 | J.P. Morgan, Deutsche Bank Securities, Evercore ISI |
| Nucana PLC | NCNA | $14.00-$16.00 | 6.67 million | 9/28/2017 | Citigroup, Jefferies, Cowen |
| Nurix Therapeutics, Inc. | NRIX | $17.00-$18.00 | 11 million | 7/24/2020 | JP Morgan, Piper Sandler, Stifel |
| Nuvalent Inc. | NUVL | $16.00-$18.00 | 9.8 million | 7/29/2021 | J.P. Morgan, Cowen, Piper Sandler |
| Nuvo Group Ltd. | NUVO | Withdrawn | Withdrawn | 0/0/0 | Cantor, Berenberg, Ladenburg Thalmann |
| NYXOAH SA | NYXH | $30.88-$30.88 | 2.835 million | 7/1/2021 | Piper Sandler, Stifel, Cantor
|
| Oak Street Health, Inc. | OSH | $19.00-$20.00 | 15.6 million | 8/6/2020 | J.P. Morgan, Goldman Sachs, Morgan Stanley, William Blair, Piper Sandler |
| Obalon Therapeutics | OBLN | $14.00-$16.00 | 5 million | 10/6/2016 | UBS Investment Bank, Canaccord Genuity, Stifel |
| ObsEva SA | OBSV | $14.00-$16.00 | 6.45 million | 1/26/2017 | Credit Suisse, Jefferies, Leerink Partners |
| Ocular Therapeutix | OCUL | $14.00-$16.00 | 5 million | 7/25/2014 | Morgan Stanley, Cowen & Co., RBC Capital Markets |
| Odonate Therapeutics, LLC | ODT | $24.00-$27.00 | 6.25 million | 12/7/2017 | Goldman Sachs, Jefferies |
| Olema Pharmaceuticals, Inc. | OLMA | $16.00-$18.00 | 11 million | 11/19/2020 | J.P. Morgan, Jefferies, Cowen, Canaccord Genuity ​ |
| Olink Holding AB | OLK | $16.00-$18.00 | 17.6 million | 3/25/2021 | Goldman Sachs, Morgan Stanley, SVB Leerink |
| Omega Therapeutics Inc. | OMGA | $16.00-$18.00 | 7.4 million | 7/30/2021 | Goldman Sachs, Jefferies, Piper Sandler |
| Omthera Pharmaceuticals | OMTH | $12.00-$14.00 | 8 million | 4/11/2013 | BofA Merrill Lynch, Barclays Capital, Leerink Swann |
| Oncobiologics, Inc. | ONS | $6.00-$6.00 | 5.8 million | 5/13/2016 | Jefferies, Barclays |
| OncoMed Pharmaceuticals | OMED | $14.00-$16.00 | 4.8 million | 7/18/2013 | Jefferies, Leerink Swann |
| Onconova Therapeutics | ONTX | $12.00-$14.00 | 5.2 million | 7/25/2013 | Citigroup, Leerink Swann |
| Oncorus, Inc | ONCR | $14.00-$16.00 | 5.8 million | 10/2/2020 | Jefferies, Evercore ISI, Piper Sandler |
| Opgen, Inc. | OPGN | $8.00-$10.00 | 2.85 million | 5/5/2015 | Maxim Group LLC |
| Ophthotech Corporation | OPHT | $16.00-$19.00 | 2.28 million | 9/25/2013 | Morgan Stanley, J.P. Morgan |
| Opthea Limited | OPT | $17.26-$17.26 | 9.5 million ADSs | 10/16/2020 | Citigroup, SVB Leerink |
| Optinose, Inc. | OPTN | $15.00-$17.00 | 7.5 million | 10/13/2017 | Jefferies, Piper Jaffray, BMO Capital Markets, RBC Capital Markets |
| Orchard Rx Limited | ORTX | $14.00-$16.00 | 14.3 million ADSs | 10/31/2018 | J.P. Morgan, Goldman Sachs, Cowen |
| Oric Pharmaceuticals Inc. | ORIC | $14.00-$16.00 | 7.5 million | 4/24/2020 | J.P. Morgan, Citigroup, Jefferies, Guggenheim Securities |
| Orphazyme A/S | ORPH | $13.13-$13.13 | 7.6 million ADSs | 9/29/2020 | BofA Securities, Cowen, Guggenheim |
| Ortho Clinical Diagnostics Holdings plc | OCDX | $20.00-$23.00 | 76 million | 1/28/2021 | J.P. Morgan, BofA Securities, Goldman Sachs, Barclays, Morgan Stanley, Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler |
| OrthoPediatrics Corp. | KIDS | $12.00-$14.00 | 4 million | 10/12/2017 | Piper Jaffray, Stifel |
| Oscar Health, Inc. | OSCR | $36.00-$38.00 | 37.1 million | 3/3/2021 | Goldman Sachs, Morgan Stanley, Allen & Company, Wells Fargo Securities, BofA Securities, Credit Suisse |
| Osmotica Pharmaceuticals plc | OSMT | $14.00-$16.00 | 6.65 million | 10/18/2018 | Jefferies, Barclays, RBC, Wells Fargo |
| Otonomy, Inc. | OTIC | $14.00-$16.00 | 6.25 million | 8/13/2014 | J.P. Morgan, BofA Merrill Lynch |
| Outset Medical Inc. | OM | $22.00-$24.00 | 8.95 million | 9/15/2020 | BofA Securities, Morgan Stanley, Goldman Sachs, SVB Leerink, Stifel |
| Ovid Therapeutics Inc. | OVID | $15.00-$17.00 | 5 million | 5/5/2017 | Citigroup, Cowen and Company |
| Oxford Immunotec Global PLC | OXFD | $13.00-$15.00 | 5.36 million | 11/22/2013 | J.P. Morgan, Piper Jaffray |
| Oyster Point Pharma, Inc | OYST | $16.00-$18.00 | 5 million | 10/31/2019 | JP Morgan, Cowen, Piper Jaffray |
| PACS Group, Inc. | PACS | 21.4 million | $20.00-$22.00 | 4/11/2024 | Citigroup, J.P. Morgan, Truist |
| Pandion Therapeutics, Inc. | PAND | $16.00-$18.00 | 7.5 million | 7/17/2020 | Goldman Sachs, Morgan Stanley, SVB Leerink, BMO Capital Markets |
| Paragon 28, Inc. | FNA | $15.00-$17.00 | 7.8 million | 10/15/2021 | BofA Securities, Piper Sandler |
| Parnell Pharmaceutical Holdings Ltd | PARN | $10.00-$10.00 | 5 million | 6/18/2014 | Jefferies, Piper Jaffray |
| Passage Bio, Inc. | PASG | $16.00-$18.00 | 12 million | 2/28/2020 | JP Morgan, Goldman Sachs, Cowen |
| Patheon N.V. | PTHN | $19.00-$22.00 | 29.76 million | 7/21/2016 | J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank,Credit Suisse, Evercore ISI, Wells Fargo Securities |
| Peloton Therapeutics, Inc. | PLTX | Withdrawn | Withdrawn | 5/23/2019 | JP Morgan, Citigroup, Jefferies |
| Penumbra, Inc. | PEN | $25.00-$28.00 | 4 million | 9/18/2015 | J.P. Morgan, BofA Merrill Lynch |
| PepGen Inc. | PEPG | $13.00-$15.00 | 9 million | 5/6/2022 | BofA Securities, SVB Leerink, Stifel |
| Personalis, Inc. | PSNL | $14.00-$16.00 | 7.92 million | 6/20/2019 | Morgan Stanley, BofA Merrill Lynch, Cowen |
| Perspectum Group plc | SCAN | Withdrawn | Withdrawn | 7/16/2021 | Citigroup, Barclays, Stifel, Canaccord Genuity
|
| PetIQ, Inc. | PETQ | $14.00-$16.00 | 6.25 million | 7/21/2017 | Jefferies, William Blair |
| Pfenex, Inc. | PFNX | $8.00-$8.00 | 8.33 million | 7/24/2014 | William Blair, JMP Securities |
| Pharvaris B.V. | PHVS | $17.00-$19.00 | 8.3 million | 2/5/2021 | Morgan Stanley, BofA Securities, SVB Leerink |
| PhaseBio Pharmaceuticals | PHAS | $12.00-$14.00 | 9.2 million | 10/18/2018 | Citigroup, Cowen, Stifel |
| PhaseRx, Inc. | PZRX | $5.00-$7.00 | 3.7 million | 5/18/2016 | Laidlaw & Co., Roth Capital Partners |
| Phathom Pharmaceuticals, Inc. | PHAT | $18.00-$20.00 | 9.6 million | 10/25/2019 | Goldman Sachs, Jefferies, Evercore ISI |
| Phibro Animal Health Corporation | PAHC | $16.00-$18.00 | 12.745 million | 4/11/2014 | BofA Merrill Lynch, Morgan Stanley, Barclays |
| Phreesia, Inc. | PHR | $15.00-$17.00 | 9.3 million | 7/18/2019 | JP Morgan, Wells Fargo Securities, William Blair, Allen & Co., Piper Jaffray |
| Pliant Therapeutics, Inc. | PLRX | $14.00-$16.00 | 9 million | 6/3/2020 | Citigroup, Cowen, Piper Sandler |
| PLX Pharma | PLXP | $17.00-$19.00 | 3.8 million | 0/0/0 | Raymond James, Maxim Group LLC |
| PMV Pharmaceuticals, Inc | PMVP | $16.00-$18.00 | 11.8 million | 9/25/2020 | Goldman Sachs, BofA Securities, Cowen, Evercore ISI
|
| PolyPid Ltd. | PYPD | $15.00-$17.00 | 3.8 million | 6/26/2020 | Barclays, BMO Capital |
| Portola Pharmaceuticals | PTLA | $13.00-$16.00 | 8.4 Million | 5/22/2013 | Morgan Stanley, Credit Suisse |
| Poseida Therapeutics, Inc. | PSTX | $16.00-$16.00 | 14 million | 7/10/2020 | BofA Securities, Piper Sandler, William Blair |
| PPD, Inc. | PPD | $24.00-$27.00 | 60 million | 2/6/2020 | Barclays, JP Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank, Evercore ISI, HSBC, Mizuho Securities
|
| PRA Health Sciences, Inc. | PRAH | $20.00-$23.00 | 16.98 million | 11/13/2014 | Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse, Wells Fargo Securities
|
| Praxis Precision Medicines, Inc. | PRAX | $17.00-$18.00 | 10 million | 10/16/2020 | Cowen, Evercore ISI, Piper Sandler
|
| Precision BioSciences, Inc. | DTIL | $15.00-$17.00 | 7.9 million | 3/28/2019 | J.P. Morgan, Goldman Sachs & Co., Jefferies, Barclays |
| Prelude Therapeutics Incorporated | PRLD | $17.00-$19.00 | 8.3 million | 9/25/2020 | Morgan Stanley, Goldman Sachs, BofA Securities |
| Presbia PLC | LENS | $11.00-$13.00 | 4.2 million | 1/29/2015 | Jefferies |
| Press Ganey Holdings | PGND | $22.00-$24.00 | 8.9 million | 5/21/2015 | Barclays, Goldman Sachs & Co., William Blair, Wells Fargo Securities
|
| Prevail Therapeutics Inc. | PRVL | $16.00-$18.00 | 7.4 million | 6/20/2019 | Morgan Stanley, BofA Merrill Lynch, Cowen |
| Prime Medicine, Inc. | PRME | $16.00-$18.00 | 10.3 million | 10/20/2022 | J.P. Morgan, Goldman Sachs & Co., Morgan Stanley, Jefferies |
| Principia Biopharma Inc. | PRNB | $15.00-$17.00 | 6.3 million | 9/14/2018 | BofA Merrill Lynch, Leerink, Wells Fargo |
| Privia Health Group, Inc. | PRVA | $21.00-$23.00 | 19.5 million | 4/29/2021 | Goldman Sachs, JP Morgan, Credit Suisse, Piper Sandler, William Blair, Canaccord Genuity, Truist Securities |
| Progenity, Inc. | PROG | $14.00-$16.00 | 6.66 million | 6/19/2020 | Piper Sandler, Wells Fargo Securities |
| Progyny, Inc. | PGNY | $14.00-$16.00 | 10 million | 10/25/2019 | J.P. Morgan, Goldman Sachs & Co, BofA Merrill Lynch, Citigroup |
| Prolung, Inc. | LUNG | Withdrawn | Withdrawn | 0/0/0 | Maxim Group, Aegis |
| Prometheus Biosciences, Inc. | RXDX | $18.00-$19.00 | 10 million | 3/12/2021 | SVB Leerink, Credit Suisse, Stifel, Guggenheim Securities
|
| ProNAi Therapeutics | DNAI | $14.00-$16.00 | 8.1 million | 7/16/2015 | Jefferies, BofA Merrill Lynch |
| Proqr Therapeutics B.V. | PRQR | $11.00-$13.00 | 7.5 million | 9/18/2014 | Leerink Partners, Deutsche Bank Securities |
| Prosensa Holding B.V. | RNA | $11.00-$13.00 | 6 million | 6/28/2013 | J.P. Morgan, Citigroup, Leerink Swann |
| Protagonist Therapeutics | PTGX | $12.00-$12.00 | 7.5 million | 8/11/2016 | Leerink Partners, Barclays, BMO Capital Markets |
| Proteon Therapeutics, Inc. | PRTO | $12.00-$14.00 | 6.1 million | 10/22/2014 | Stifel, JMP Securities |
| Proteostasis Therapeutics | PTI | $12.00-$14.00 | 6.25 million | 2/11/2016 | Leerink Partners, RBC Capital Markets |
| Provention Bio, Inc. | PRVB | $4.00-$4.00 | 15.97 million | 7/24/2018 | MDB Capital Group |
| PTC Therapeutics | PTCT | $13.00-$16.00 | 8.4 million | 6/20/2013 | J.P. Morgan, Credit Suisse |
| Pulmonx Corporation | LUNG | $17.00-$18.00 | 10 million | 10/1/2020 | BofA Securities, Morgan Stanley |
| Pulse Biosciences | PLSE | $4.00-$4.00 | 5 million | 5/18/2016 | MDB Capital Group LLC, Feltl and Company |
| Pyxis Oncology, Inc. | PYXS | $14.00-$16.00 | 10.5 million | 10/8/2021 | BofA Securities, Jefferies, Credit Suisse, William Blair |
| Quanterix Corporation | QTRX | $14.00-$16.00 | 4.28 million | 12/7/2017 | J.P. Morgan, Leerink, Cowen |
| Quintiles Transnational | Q | $36.00-$40.00 | 23.7 million | 5/9/2013 | Morgan Stanley, Barclays, J.P. Morgan |
| Quotient Limited | QTNTU | $14.00-$16.00 | 5 million | 4/25/2014 | UBS Investment Bank, Baird, Cowen & Co. |
| Ra Medical Systems, Inc. | RMED | $14.00-$16.00 | 3.9 million | 9/27/2018 | Piper Jaffray, Cantor |
| RA Pharmaceuticals | RARX | $12.00-$14.00 | 7.05 million | 10/26/2016 | Credit Suisse, Jefferies, BMO Capital Markets |
| Radius Health | RDUS | $8.00-$8.00 | 6.5 million | 6/6/2014 | Jefferies, Cowen & Co. |
| Rain Therapeutics Inc. | RAIN | $16.00-$18.00 | 7.35 million | 4/23/2021 | Goldman Sachs, Citigroup, Piper Sandler, Guggenheim Securities |
| Rallybio Corporation | RLYB | $13.00-$15.00 | 6.2 million | 7/29/2021 | Jefferies, Cowen, Evercore |
| Rani Therapeutics Inc. | RANI | $14.00-$16.00 | 6.67 million | 7/30/2021 | BofA Securities, Stifel, Cantor, Canaccord Genuity |
| Rapid Micro Biosystems, Inc. | RPID | $18.00-$20.00 | 7.9 million | 7/15/2021 | JP Morgan, Morgan Stanley, Cowen, Stifel |
| Rapport Therapeutics, Inc. | RAPP | $16.00-$18.00 | 8 million | 6/7/2024 | Goldman Sachs, Jefferies, TD Cowen, Stifel |
| RAPT Therapeutics, Inc. | RAPT | $12.00-$14.00 | 3 million | 10/31/2019 | BMO Capital, Wells Fargo Securities, UBS Investment Bank |
| RayzeBio, Inc. | RYZB | $16.00-$18.00 | 17.3 million | 9/15/2023 | J.P. Morgan, Jefferies, Evercore ISI, Truist Securities |
| Realm Therapeutics plc | RLM | TBD | 5.07 million ADSs | 0/0/0 | TBD |
| Reata Pharmaceuticals | RETA | $14.00-$16.00 | 5.5 million | 5/26/2016 | Citigroup, Cowen & Co., Piper Jaffray |
| Receptos | RCPT | $14.00-$16.00 | 5.2 million | 5/9/2013 | Credit Suisse, Leerink Swann, BMO Capital Markets |
| Recursion Pharmaceuticals, Inc. | RXRX | $16.00-$18.00 | 24.2 million | 4/16/2021 | Goldman Sachs, JP Morgan, BofA Securities, SVB Leerink, Allen & Co. |
| REGENXBIO, Inc. | RGNX | $17.00-$19.00 | 6.3 million | 9/17/2015 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Regulus Therapeutics Inc. | RGLS | $10.00-$12.00 | 11.25 million | 9/7/2012 | Lazard Capital Markets, Cowen and Company, BMO Capital Markets
|
| Relay Therapeutics, Inc. | RLAY | $18.00-$19.00 | 20 million | 7/16/2020 | JP Morgan, Goldman Sachs, Cowen, Guggenheim Securities |
| Relypsa | RLYP | $16.00-$19.00 | 6.9 million | 11/15/2013 | Morgan Stanley, BofA Merrill Lynch |
| Renalytix AI plc | RNLX | $14.22-$14.22 | 5.5 million ADSs | 7/17/2020 | JP Morgan, Stifel |
| Reneo Pharmaceuticals, Inc. | RPHM | $15.00-$17.00 | 6.25 million | 4/9/2021 | Jefferies, SVB Leerink, Piper Sandler |
| Repare Therapeutics Inc. | RPTX | $16.00-$18.00 | 11 million | 6/19/2020 | Morgan Stanley, Goldman Sachs, Cowen, Piper Sandler |
| Replimune Group, Inc. | REPL | $14.00-$16.00 | 6.7 million | 7/20/2018 | J.P. Morgan, Leerink Partners, BMO Capital Markets |
| Restoration Robotics, Inc. | HAIR | $7.00-$9.00 | 3.57 million | 10/12/2017 | National Securities Corporation |
| resTORbio, Inc. | TORC | $14.00-$16.00 | 5.67 million | 1/26/2018 | BofA Merrill Lynch, Leerink Partners, Evercore ISI |
| Revance Therapeutics, Inc. | RVNC | $14.00-$16.00 | 6 million | 2/6/2014 | Cowen & Co., Piper Jaffray |
| Revolution Medicines, Inc. | RVMD | $16.00-$17.00 | 14 million | 2/13/2020 | JP Morgan, Cowen, SVB Leerink, Guggenheim |
| ReWalk Robotics Ltd. | RWLK | $14.00-$16.00 | 3 million | 9/12/2014 | Barclays, Jefferies |
| Rhythm Pharmaceuticals, Inc. | RYTM | $14.00-$16.00 | 7.05 million | 10/5/2017 | Morgan Stanley, BofA Merrill Lynch, Cowen & Co. |
| Ritter Pharmaceuticals | RTTR | $5.00-$5.00 | 4 million | 6/24/2015 | Aegis Capital Corp, Chardan Capital Markets |
| Roka Biosciences | ROKA | $14.00-$16.00 | 5 million | 7/17/2014 | BofA Merrill Lynch, Leerink Partners |
| Rotech Healthcare Holdings, Inc. | ROTK | TBD | TBD | 0/0/0 | BofA Securities, Jefferies, UBS Investment Bank, Truist Securities, Baird, RBC Capital Markets |
| Royalty Pharma plc | RPRX | $25.00-$28.00 | 77.7 million | 6/16/2020 | JP Morgan, Morgan Stanley, BofA Securities, Goldman Sachs, Citigroup, UBS, Evercore ISI, Cowen, SunTrust Robinson Humphrey |
| Rubius Therapeutics, Inc. | RUBY | $20.00-$22.00 | 10.5 million | 7/18/2018 | J.P. Morgan, Morgan Stanley, Jefferies, Leerink Partners |
| RxSight, Inc. | RXST | $16.00-$18.00 | 7.35 million | 7/30/2021 | JP Morgan, BofA Securities, SVB Leerink, Wells Fargo Securities, BTIG
|
| Sage Therapeutics | SAGE | $17.00-$18.00 | 5 million | 7/18/2014 | J.P. Morgan, Goldman Sachs & Co. |
| Sagimet Biosciences Inc. | SGMT | $15.00-$17.00 | 5.3 million | 7/14/2023 | Goldman Sachs, Cowen, Piper Sandler |
| Sana Biotechnology, Inc. | SANA | $23.00-$24.00 | 23.5 million | 2/4/2021 | Morgan Stanley, Goldman Sachs, J.P. Morgan, BofA Securities |
| Sancilio Pharmaceuticals | SPCI | TBD | TBD | 0/0/0 | UBS Investment Bank, Piper Jaffray |
| Satsuma Pharmaceuticals, Inc. | STSA | $14.00-$16.00 | 5.5 million | 9/13/2019 | Credit Suisse, SVB Leerink, Evercore |
| Scholar Rock Holding Corporation | SRRK | $13.00-$15.00 | 5.4 million | 5/24/2018 | Jefferies, Cowen, BMO Capital |
| Schrodinger Inc. | SDGR | $14.00-$16.00 | 11.9 million | 2/6/2020 | Morgan Stanley, BofA Securities, Jefferies, BMO Capital Markets
|
| scPharmaceuticals, Inc. | SCPH | $14.00-$16.00 | 6.4 million | 11/17/2017 | Jefferies, Leerink, BMO Capital Markets |
| SCYNEXIS, Inc. | SCYX | $10.00-$10.00 | 6.2 million | 5/2/2014 | RBC Capital Markets, Canaccord Genuity |
| Second Sight Medical Products | EYES | $9.00-$9.00 | 3.5 million | 11/19/2014 | MDB Capital Group LLC |
| Seer, Inc. | SEER | $16.00-$18.00 | 9.2 million | 12/4/2020 | J.P. Morgan, Morgan Stanley, BofA Securities, Cowen |
| Selecta Biosciences | SELB | $14.00-$16.00 | 5 Million | 6/22/2016 | UBS Investment Bank, Stifel |
| SenesTech, Inc. | SNES | $12.00-$14.00 | 1.875 million | 12/8/2016 | Roth Capital Partners |
| Sensei Biotherapeutics, Inc. | SNSE | $16.00-$18.00 | 7 million | 2/4/2021 | Citigroup, Piper Sandler, Berenberg |
| Sensus Healthcare | SRTS | $6.25-$6.25 | 2 million | 6/3/2016 | Northland Capital Markets, Neidiger Tucker Bruner Inc |
| Septerna, Inc. | SEPN | $15.00-$17.00 | 16 million | 10/25/2024 | J.P. Morgan, TD Cowen, Cantor, Wells Fargo Securities |
| Sera Prognostics, Inc. | SERA | $15.00-$17.00 | 4.7 million | 7/15/2021 | Citigroup, Cowen, William Blair
|
| Seres Therapeutics | MCRB | $15.00-$17.00 | 7.43 million | 6/26/2015 | Goldman Sachs & Co., BofA Merrill Lynch |
| Shattuck Labs, Inc. | STTK | $14.00-$16.00 | 11.9 million | 10/9/2020 | Citigroup, Cowen, Evercore ISI |
| ShockWave Medical, Inc. | SWAV | $14.00-$16.00 | 5.7 million | 3/7/2019 | Morgan Stanley, BofA Merrill Lynch |
| SI-BONE, Inc. | SIBN | $13.00-$15.00 | 7.2 million | 10/17/2018 | Morgan Stanley, BofA Merrill Lynch |
| Sienna Biopharmaceuticals, Inc. | SNNA | $14.00-$16.00 | 4.33 million | 7/27/2017 | J.P. Morgan, Cowen, BMO Capital Markets |
| Sientra, Inc. | SIEN | $14.00-$16.00 | 5 million | 10/29/2014 | Piper Jaffray, Stifel
|
| Sight Sciences, Inc. | SGHT | $23.00-$24.00 | 10 million | 7/15/2021 | Morgan Stanley, BofA Securities, Citigroup, Piper Sandler |
| Sigilon Therapeutics, Inc. | SGTX | $17.00-$19.00 | 7 million | 12/4/2020 | Morgan Stanley, Jefferies, Barclays, Canaccord Genuity
|
| Signify Health, Inc. | SGFY | $20.00-$21.00 | 23.5 million | 2/11/2021 | Goldman Sachs, JP Morgan, Barclays, Deutsche Bank Securities, BofA Securities, UBS Investment Bank, Baird, Piper Sandler, William Blair |
| Silk Road Medical, Inc. | SILK | $15.00-$17.00 | 6 million | 4/4/2019 | JP Morgan, BofA Merrill Lynch |
| Silverback Therapeutics, Inc. | SBTX | $19.00-$20.00 | 11.5 million | 12/4/2020 | Goldman Sachs, SVB Leerink, Stifel |
| Singular Genomics Systems Inc. | OMIC | $20.00-$22.00 | 10.2 million | 5/27/2021 | JP Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank |
| SmileDirectClub, Inc. | SDC | $19.00-$22.00 | 58.5 million | 9/12/2019 | J.P. Morgan, Citigroup, BofA Merrill Lynch, Jefferies, UBS Investment Bank, Credit Suisse |
| Sol-Gel Technologies, Ltd. | SLGL | $11.00-$13.00 | 6.25 million | 2/1/2018 | Jefferies, BMO Capital Markets |
| Solid Biosciences Inc. | SLDB | $18.00-$19.00 | 7.5 million | 1/25/2018 | J.P. Morgan, Goldman Sachs & Co., Leerink Partners |
| Solta Medical Corporation | SLTA | Withdrawn | Withdrawn | 0/0/0 | Goldman Sachs, Morgan Stanley, Citigroup, Guggenheim Securities, Barclays, Evercore ISI |
| Sonendo, Inc. | SONX | $15.00-$17.00 | 7.8 million | 10/29/2021 | BofA Securities, Goldman Sachs, Piper Sandler, Stifel |
| SOPHiA GENETICS SA | SOPH | $17.00-$19.00 | 13 million | 7/23/2021 | J.P. Morgan, Morgan Stanley, Cowen, Credit Suisse |
| Sotera Health Company | SHC | $20.00-$23.00 | 46.6 million | 11/20/2020 | J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup, RBC Capital Markets |
| Spark Therapeutics | ONCE | $15.00-$17.00 | 7 million | 1/30/2015 | J.P. Morgan, Credit Suisse |
| Spero Therapeutics, Inc. | SPRO | $14.00-$16.00 | 5.5 million | 11/2/2017 | BofA Merrill Lynch, Cowen & Company, Stifel |
| Spinal Elements Holdings, Inc. | SPEL | Postponed | Postponed | 10/15/2020 | Credit Suisse, Baird, Stifel |
| Spring Bank Pharmaceuticals | SBPH | $12.00-$14.00 | 0.92 million | 5/6/2016 | Dawson James Securities |
| SpringWorks Therapeutics, Inc. | SWTX | $16.00-$18.00 | 9.0 million | 9/13/2019 | JP Morgan, Goldman Sachs, Cowen |
| Spruce Biosciences, Inc. | SPRB | $14.00-$16.00 | 6 million | 10/9/2020 | Cowen, SVB Leerink, Credit Suisse, RBC Capital |
| SQZ Biotechnologies Company | SQZ | $16.00-$18.00 | 4.4 million | 10/30/2020 | BofA Securities, Stifel |
| SteadyMed Ltd. | STDY | $12.00-$14.00 | 4.7 million | 3/20/2015 | Wells Fargo Securities, RBC Capital Markets |
| Stealth BioTherapeutics Inc. | MITO | $12.00-$14.00 | 6.5 million ADSs | 2/15/2019 | Jefferies, Evercore, BMO Capital |
| Stemline Therapeutics | STML | $10.00-$12.00 | 3.3 million | 1/29/2013 | Aegis Capital Corp |
| Stevenato Group S.A. | STVN | $21.00-$24.00 | 32 million | 7/16/2021 | Morgan Stanley, BofA Securities, Jefferies, Citigroup, KeyBanc Capital, UBS Investment, Wells Fargo, William Blair |
| Stoke Therapeutics, Inc. | STOK | $14.00-$16.00 | 7.9 million | 6/19/2019 | JP Morgan, Cowen, Credit Suisse |
| Structure Therapeutics Inc. | GPCR | $13.00-$15.00 | 10.7 million | 2/3/2023 | Jefferies, SVB Securities, Guggenheim Securities, BMO Capital Markets |
| Surface Oncology, Inc. | SURF | $13.00-$15.00 | 7.2 million | 4/19/2018 | Goldman Sachs, Cowen, Evercore ISI |
| Surgery Partners, Inc. | SGRY | $23.00-$26.00 | 14.3 million | 10/1/2015 | BofA Merrill Lynch, Goldman Sachs & Co., Jefferies |
| Surgical Care Affiliates | SCAI | $21.00-$24.00 | 9.8 million | 10/30/2013 | J.P. Morgan, Citigroup |
| SurgiQuest, Inc. | TBD | TBD | TBD | 0/0/0 | Piper Jaffray, Stifel, Canaccord Genuity |
| Sutro Biopharma, Inc. | STRO | $14.00-$16.00 | 5.667 million | 9/27/2018 | Cowen, Piper Jaffray |
| Syndax Pharmaceuticals, Inc. | SNDX | $14.00-$16.00 | 4.4 million | 3/3/2016 | Morgan Stanley, Citigroup
|
| Synthorx, Inc. | THOR | $10.00-$12.00 | 11.9 million | 12/7/2018 | Jefferies, Leerink, Evercore ISI |
| Syros Pharmaceuticals | SYRS | $14.00-$16.00 | 4 million | 6/30/2016 | Cowen & Co., Piper Jaffray |
| T2 Biosystems, Inc. | TTOO | $15.00-$17.00 | 5.2 million | 8/7/2014 | Goldman Sachs & Co., Morgan Stanley |
| Tabula Rasa HealthCare | TRHC | $13.00-$15.00 | 4.3 million | 9/29/2016 | Wells Fargo Securities, UBS Investment Bank, Piper Jaffray |
| Tactile Systems Technology | TCMD | $14.00-$16.00 | 4 million | 7/28/2016 | Piper Jaffray, William Blair, Canaccord Genuity |
| Talaris Therapeutics, Inc. | TALS | $16.00-$18.00 | 8.8 million | 5/7/2021 | Morgan Stanley, SVB Leerink, Evercore ISI, Guggenheim Securities |
| Talis Biomedical Corporation | TLIS | $14.00-$16.00 | 13.8 million | 2/12/2021 | JP Morgan, BofA Securities, Piper Sandler |
| Tandem Diabetes Care | TNDM | $13.00-$15.00 | 8.0 million | 11/14/2013 | BofA Merrill Lynch, Piper Jaffray |
| Tarsus Pharmaceuticals, Inc. | TARS | $15.00-$17.00 | 5.5 million | 10/16/2020 | BofA Securities, Jefferies, Raymond James
|
| Taysha Gene Therapies, Inc. | TSHA | $18.00-$20.00 | 7.9 million | 9/24/2020 | Goldman Sachs, Morgan Stanley, Jefferies |
| TCR2 Therapeutics Inc. | TCRR | $14.00-$16.00 | 5 million | 2/14/2019 | Jefferies, SVB Leerink, BMO Capital |
| TELA Bio, Inc. | TELA | $14.00-$16.00 | 4 million | 11/8/2019 | Jefferies, Piper Jaffray, Canaccord Genuity |
| Teladoc, Inc. | TDOC | $15.00-$17.00 | 8.25 million | 7/1/2015 | J.P. Morgan, Deutsche Bank Securities |
| Tenaya Therapeutics, Inc. | TNYA | $14.00-$16.00 | 12 million | 7/30/2021 | Morgan Stanley, Cowen, Piper Sandler |
| Terns Pharmaceuticals, Inc. | TERN | $15.00-$17.00 | 7.5 million | 2/5/2021 | JP Morgan, Goldman Sachs, Cowen |
| Tesaro | TSRO | $12.00-$15.00 | 6.0 million | 6/28/2014 | Citigroup, Morgan Stanley, Leerink Swann |
| TetraLogic Pharmaceuticals | TLOG | $7.00-$7.00 | 7.2 million | 12/12/2013 | Oppenheimer & Co., Guggenheim Securities, Needham & Co. |
| Tetraphase Pharmaceuticals | TTPH | $10.00-$12.00 | 10.7 million | 3/20/2013 | Barclays, BMO Capital Markets |
| Thar Pharmaceuticals, Inc. | THAR | Withdrawn | Withdrawn | 0/0/0 | SunTrust Robinson Humphrey |
| The Joint Corp. | JYNT | $9.00-$11.00 | 3 million | 11/11/2014 | Roth Capital Partners, Feltl and Company
|
| Theseus Pharmaceuticals, Inc. | THRX | $14.00-$16.00 | 10 million | 10/7/2021 | Jefferies, SVB Leerink, Cantor |
| Third Harmonic Bio, Inc. | THRD | $16.00-$18.00 | 10.9 million | 9/15/2022 | Morgan Stanley, Jefferies, Cowen |
| Thorne HealthTech, Inc. | THRN | $10.00-$11.00 | 7 million | 9/23/2021 | BofA Securities, Cowen, Evercore ISI, RBC Capital Markets |
| Tocagen, Inc. | TOCA | $10.00-$12.00 | 8.5 million | 4/13/2017 | Leerink Partners, Evercore ISI, Stifel |
| Tokai Pharmaceuticals, Inc. | TKAI | $13.00-$15.00 | 6.48 miillion | 9/17/2014 | BMO Capital Markets, Stifel, William Blair |
| Tracon Pharmaceutical | TCON | $12.00-$14.00 | 3.6 million | 1/30/2015 | Wells Fargo Securities, Stifel |
| Translate Bio, Inc. | TBIO | $12.00-$14.00 | 9.4 million | 6/28/2018 | Citigroup, Leerink Partners, Evercore ISI |
| TransMedics Group, Inc. | TMDX | $15.00-$17.00 | 5.7 million | 5/2/2019 | Morgan Stanley, JP Morgan |
| Tranzyme | TZYM | $4.00-$4.00 | 13.5 million | 4/4/2011 | Citigroup |
| Treace Medical Concepts, Inc. | TMCI | $15.00-$17.00 | 11.25 million | 4/23/2021 | JP Morgan, Morgan Stanley |
| Trevena | TRVN | $7.00-$7.00 | 9.3 million | 1/31/2014 | Barclays, Jefferies |
| Trevi Therapeutics, Inc. | TRVI | $14.00-$16.00 | 5.5 million | 5/7/2019 | SVB Leerink, Stifel, BMO Capital |
| Tricida, Inc. | TCDA | $16.00-$18.00 | 11.7 million | 6/28/2018 | Goldman Sachs, J.P. Morgan, Cowen
|
| Trivascular Technologies, Inc. | TRIV | $13.00-$15.00 | 6.5 million | 4/16/2014 | J.P. Morgan, Credit Suisse |
| Trupanion Inc. | TRUP | $13.00-$15.00 | 7.1 million | 7/18/2014 | RBC Capital Markets, Barclays, Stifel |
| TScan Therapeutics, Inc. | TCRX | $15.00-$17.00 | 6.67 million | 7/16/2021 | Morgan Stanley, Jefferies, Cowen, Barclays |
| Turning Point Therapeutics, Inc. | TPTX | $16.00-$18.00 | 9.25 million | 4/17/2019 | Goldman Sachs & Co. LLC, SVB Leerink, Wells Fargo Securities |
| Turnstone Biologics Corp | TSBX | $12.00-$14.00 | 6.7 million | 7/21/2023 | BofA Securities, SVB Securities, Piper Sandler |
| Twist Bioscience Corporation | TWST | $14.00-$16.00 | 5 million | 10/31/2018 | J.P. Morgan, Cowen |
| Tyra Biosciences, Inc. | TYRA | $14.00-$16.00 | 10.8 million | 9/15/2021 | BofA Securities, Jefferies, Cowen |
| Ultragenyx Pharmaceutical | RARE | $14.00-$17.00 | 5.8 million | 1/31/2014 | J.P. Morgan, Morgan Stanley |
| Unicycive Therapeutics Inc. | UNCY | $5.00-$6.00 | 5 million | 7/13/2021 | Roth Capital |
| uniQure B.V. | QURE | $13.00-$15.00 | 5.4 million | 2/5/2014 | Jefferies, Leerink Swann, Piper Jaffray |
| Unity Biotechnology, Inc. | UBX | $16.00-$18.00 | 5 million | 5/3/2018 | Goldman Sachs & Co., Morgan Stanley, Citigroup |
| Unum Therapeutics, Inc. | UMRX | $12.00-$14.00 | 5.77 million | 3/29/2018 | Morgan Stanley, Cowen |
| Upstream Bio, Inc. | UPB | $15.00-$17.00 | 15 million | 10/11/2024 | JP Morgan, TD Cowen, Piper Sandler, William Blair |
| UroGen Pharma Ltd. | URGN | $12.00-$14.00 | 4.47 milliion | 5/4/2017 | Jefferies, Cowen and Company |
| Urovant Sciences Ltd. | UROV | $14.00-$16.00 | 10 million | 9/27/2018 | J.P. Morgan, Jefferies, Cowen |
| Vaccinex, Inc. | VCNX | $12.00-$15.00 | 3.3 million | 8/9/2018 | Oppenheimer & Co., BTIG |
| Vaccitech plc. | VACC | $16.00-$18.00 | 6.5 million ADSs | 4/30/2021 | Morgan Stanley, Jefferies, Barclays, William Blair |
| Valneva SE | VALN | $24.04-$28.85 | 2.3 million ADSs | 5/6/2021 | Goldman Sachs, Jefferies, Guggenheim Securities, Bryan Garnier & Co. |
| Vanguard Health Systems, Inc. | VHS | Priced at $18.00 | 25 million | 6/22/2011 | BofA Merrill Lynch, Barclays Capital, Citigroup, Deutsche Bank Securities, J.P. Morgan |
| Vapotherm, Inc. | VAPO | $14.00-$16.00 | 4 million | 11/14/2018 | BofA Merrill Lynch, William Blair |
| Vascular Biogenics, Ltd. | VBLT | $13.00-$15.00 | 6.66 million | 10/1/2014 | Deutsche Bank Securities |
| Vaxcyte, Inc. | PCVX | $14.00-$16.00 | 15.625 million | 6/12/2020 | BofA Securities, Jefferies, Evercore ISI |
| Vaxxinity, Inc. | VAXX | $14.00-$16.00 | 6 million | 11/11/2021 | BofA Securities, Jefferies, Evercore ISI |
| VectivBio Holding AG | VECT | $16.00-$18.00 | 7.5 million | 4/9/2021 | BofA Securities, SVB Leerink, Credit Suisse |
| Ventyx Biosciences, Inc. | VTYX | $15.00-$17.00 | 9.5 million | 10/21/2021 | Jefferies, Evercore ISI, Piper Sandler |
| Vera Therapeutics, Inc. | VERA | $14.00-$16.00 | 4.35 million | 5/14/2021 | Jefferies, Cowen, Evercore ISI |
| Veracyte, Inc. | VCYT | $13.00-$15.00 | 5 million | 10/30/2013 | Morgan Stanley, Leerink Swann |
| Verastem, Inc. | VSTM | $9.00-$11.00 | 5.5 million | 1/27/2012 | Jefferies, Leerink Swann |
| Verrica Pharmaceuticals Inc. | VRCA | $14.00-$16.00 | 5 million | 6/15/2018 | BofA Merrill Lynch, Jefferies, Cowen |
| Versartis, Inc. | VSAR | $16.00-$19.00 | 6 million | 3/21/2014 | Morgan Stanley, Citigroup |
| Verve Therapeutics, Inc. | VERV | $16.00-$18.00 | 14.035 million | 6/17/2021 | JP Morgan, Jefferies, Guggenheim Securities, William Blair |
| Viela Bio, Inc. | VIE | $19.00-$21.00 | 7.9 million | 10/3/2019 | Goldman Sachs, Morgan Stanley, Cowen
|
| Vigil Neuroscience, Inc. | VIGL | $15.00-$17.00 | 7 million | 1/7/2022 | Morgan Stanley, Jefferies, Stifel, Guggenheim Securities |
| Viking Therapeutics, Inc. | VKTX | $10.00-$12.00 | 3 million | 4/29/2015 | Laidlaw & Company (UK) Ltd. |
| Vir Biotechnology, Inc. | VIR | $20.00-$22.00 | 7.1 million | 10/11/2019 | Goldman Sachs, JP Morgan, Cowen, Barclays |
| Visterra, Inc. | VIST | $12.00-$14.00 | 3.9 million | 0/0/0 | Leerink Partners, Stifel |
| Vitae Pharmaceuticals, Inc. | VTAE | $11.00-$13.00 | 6.875 million | 9/24/2014 | Stifel, BMO Capital Markets |
| Vital Therapies | VTL | $13.00-$15.00 | 4.5 million | 4/17/2014 | BofA Merrill Lynch, Credit Suisse
|
| Viventia Bio, Inc. | VITA | TBD | TBD | 0/0/0 | Leerink Securites, Cowen and Company, Guggenheim Securities |
| Vividion Therapeutics, Inc. | VVID | Withdrawn | Withdrawn | 0/0/0 | JP Morgan, BofA Securities, Jefferies
|
| Vivos Therapeutics, Inc | VVOS | $5.00-$7.00 | 3.33 million ADSs | 12/11/2020 | Roth Capital |
| Vor Biopharma, Inc. | VOR | $16.00-$18.00 | 9.8 million | 2/5/2021 | Goldman Sachs, Evercore ISI, Barclays, Stifel |
| Voyager Therapeutics | VYGR | $15.00-$17.00 | 5 million | 11/11/2015 | Cowen & Co., Piper Jaffray, Nomura, Wedbush PacGrow |
| vTv Therapeutics Inc. | VTVT | $15.00-$17.00 | 7.8 million | 7/30/2015 | Piper Jaffray, Stifel |
| Wave Life Sciences PTE, Ltd. | WVE | $15.00-$17.00 | 6.375 million | 11/11/2015 | Jefferies, Leerink Partners |
| WCG Clinical, Inc. | WCGC | Postponed | Postponed | 8/5/2021 | Goldman Sachs, Morgan Stanley, BofA Securities, Barclays, Jefferies, William Blair, BMO Capital Markets, UBS Investment Bank, SVB Leerink HSBC |
| Werewolf Therapeutics Inc. | HOWL | $15.00-$17.00 | 7.5 million | 4/30/2021 | Jefferies, SVB Leerink, Evercore ISI |
| Xactly Corporation | XTLY | $10.00-$12.00 | 7.04 million | 6/26/2015 | J.P. Morgan, Deutsche Bank Securities, UBS Investment Bank |
| XBiotech, Inc. | XBIT | $18.00-$20.00 | 4 million | 4/15/2015 | WRHambrecht + Co. |
| Xenon Pharmaceuticals | XENE | $10.00-$12.00 | 4 million | 11/5/2014 | Jefferies, Wells Fargo Securities |
| Xeris Pharmaceuticals, Inc. | XERS | $14.00-$16.00 | 5.7 million | 6/21/2018 | Jefferies, Leerink Partners, RBC Capital, Mizuho Securities |
| Xilio Therapeutics, Inc. | XLO | $16.00-$18.00 | 7.35 million | 10/22/2021 | Morgan Stanley, Cowen, Guggenheim Securities |
| Y-mAbs Therapeutics, Inc. | YMAB | $14.00-$16.00 | 6 million | 9/21/2018 | BofA Merrill Lynch, Cowen, Canaccord Genuity |
| Zafgen, Inc. | ZFGN | $14.00-$16.00 | 6 million | 6/19/2014 | Leerink Partners, Cowen and Company
|
| Zai Lab Limited | ZLAB | $16.00-$18.00 | 8.0 million ADSs | 9/20/2017 | J.P. Morgan, Citigroup, Leerink Partners |
| Zealand Pharma A/S | ZEAL | $19.30-$19.30 | 4.375 million ADS | 8/9/2017 | Morgan Stanley, Goldman Sachs & Co. |
| Zenas BioPharma, Inc. | ZBIO | $16.00-$18.00 | 13.2 million | 9/13/2024 | Morgan Stanley, Jefferies, Citigroup, Guggenheim Securities |
| Zentalis Pharmaceuticals, LLC | ZNTL | $16.00-$18.00 | 9.18 million | 4/3/2020 | Morgan Stanley, Jefferies, SVB Leerink, Guggenheim Securities |
| Zoetis Inc. | ZTS | $22.00-$25.00 | 86.1 million | 2/1/2013 | J.P. Morgan, BofA Merrill Lynch, Morgan Stanley |
| Zosano Pharma Corporation | ZSAN | $10.00-$12.00 | 4.5 million | 1/27/2015 | Ladenburg Thalmann, Roth Capital Partners |
| ZS Pharma Inc., | ZSPH | $15.00-$17.00 | 5.9 million | 6/18/2014 | J.P. Morgan, Credit Suisse |
| Zymeworks Inc. | ZYME | $13.00-$16.00 | 4.5 million | 4/28/2017 | Citigroup, Barclays, Wells Fargo Securities, |
| Zynerba Pharmaceuticals, Inc. | ZYNE | $13.00-$15.00 | 3 million | 8/5/2015 | Jefferies, Piper Jaffray |
